{"formatVersion":"1.1","id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder","path":"/library/medication-for-borderline-personality-disorder","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder","title":"Medications for Borderline Personality Disorder","family":"Library detail","description":"There aren't any medications that can treat BPD, but there are drugs that can help manage symptoms of the disorder. Find out more here.","language":"en-US","access":{"audience":"custom-shared-preview","indexable":true},"provenance":{"sourceUrl":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder","wordpressId":"320","contentCompleteness":"complete","dateScope":"original-source"},"authors":[{"@type":"Person","@id":"https://www.mentalhealth.com/people/jill-sensenig#person","name":"Jill Sensenig","url":"https://www.mentalhealth.com/people/jill-sensenig"}],"reviewer":{"@type":"Person","@id":"https://www.mentalhealth.com/people/tayler-hackett#person","name":"Tayler Hackett","url":"https://www.mentalhealth.com/people/tayler-hackett"},"dates":{"datePublished":"2023-01-12T11:53:33Z","dateModified":"2025-08-27T10:56:54Z","lastReviewed":"2023-01-12"},"content":{"html":"<div><nav aria-label=\"Breadcrumb\" class=\"breadcrumbs\"><ol><li><a href=\"https://www.mentalhealth.com/\">Home</a></li><li><a href=\"https://www.mentalhealth.com/library\">Library</a></li><li><a href=\"https://www.mentalhealth.com/library/personality-disorders\">Personality Disorders</a></li><li><span aria-current=\"page\">Medications for Borderline Personality Disorder</span></li></ol></nav><div class=\"article-page article-standard\" data-library-standard=\"\"><div class=\"article-main-grid\"><header class=\"article-heading\"><h1>Medications for Borderline Personality Disorder</h1><p class=\"article-inline-credits\"><span>Written by <a class=\"article-credit-person\" href=\"https://www.mentalhealth.com/people/jill-sensenig\"><img alt=\"\" height=\"22\" loading=\"lazy\" src=\"https://www.mentalhealth.com/assets/optimized/a31666132215697b750001da.webp\" width=\"22\" decoding=\"async\">Jill Sensenig</a></span><span>Medically reviewed by <a class=\"article-credit-person\" href=\"https://www.mentalhealth.com/people/tayler-hackett\"><img alt=\"\" height=\"22\" loading=\"lazy\" src=\"https://www.mentalhealth.com/assets/optimized/695fdf81224f51c976460925.webp\" width=\"22\" decoding=\"async\">Tayler Hackett</a></span></p><div class=\"article-dates\"><span>Published on <time datetime=\"2023-01-12T11:53:33Z\">January 12, 2023</time></span><span aria-hidden=\"true\"> · </span><span>Updated on <time datetime=\"2025-08-27T10:56:54Z\">August 27, 2025</time></span></div></header><div class=\"article-jumpbar\"></div><div class=\"article-layout\"><div class=\"article-reading\"><article class=\"prose\" id=\"article-content\"><div class=\"article-intro\" data-source-field=\"hero\"><p>There are no medications specifically approved by the U.S. Food and Drug Administration (FDA) to treat <a class=\"article-inline-link\" href=\"https://www.mentalhealth.com/library/borderline-personality-disorder\">borderline personality disorder (BPD)</a><sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan-source\" data-reference-link=\"\" aria-label=\"Reference 4: Chapman J, Jamil RT, Fleisher C. (2022, May 2). Borderline Personality Disorder. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed June 6 2023.\" data-reference-number=\"4\">[4]</a></sup>. </p><p>However, prescription medications are often used to manage the symptoms that occur with BPD, such as anxiety, sleep problems, depression, aggression, mood swings, impulsivity, or psychotic symptoms⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan-source\" data-reference-link=\"\" aria-label=\"Reference 4: Chapman J, Jamil RT, Fleisher C. (2022, May 2). Borderline Personality Disorder. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed June 6 2023.\" data-reference-number=\"4\">[4]</a></sup>. This includes medications such as antidepressants, antipsychotics, mood stabilizers, and anxiolytics (anxiety medications).</p></div><figure class=\"article-feature\"><img alt=\"A counselor takes notes during a conversation with an adult.\" decoding=\"async\" height=\"600\" loading=\"eager\" src=\"https://www.mentalhealth.com/assets/optimized/7d897f0ee39d4329bfc5ebdf.webp\" width=\"1200\"></figure><section aria-labelledby=\"key-takeaways\" class=\"article-takeaways\"><h2 id=\"key-takeaways\">Key takeaways</h2><ul><li>Medication is sometimes used to target particular symptoms or coexisting conditions in borderline personality disorder.</li><li>Potential benefits need to be weighed against adverse effects, limited evidence, and risks such as disinhibition with some sedatives.</li><li>Structured psychotherapy remains central, with approaches such as Dialectical behavior therapy (DBT) and mentalization-based treatment developing coping and relationship skills.</li></ul></section><h2 id=\"antidepressants\">Antidepressants</h2><p>Antidepressants may be prescribed for a co-occurring condition such as depression or an anxiety disorder; they do not replace psychological treatment for BPD<sup class=\"citation-group\"><a class=\"article-citation\" data-reference-number=\"19\" data-reference-link=\"\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-19\" aria-label=\"Reference 19: Pharmacological interventions for personality disorders. (n.d.). nice.org.uk. Accessed October 10 2026.\">[19]</a></sup>.</p><h3 id=\"serotonin-reuptake-inhibitors-ssris\">Serotonin reuptake inhibitors (SSRIs)</h3><p>SSRIs<strong><strong> </strong></strong>increase the level of serotonin in the brain and are used to treat BPD symptoms such as depression⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#selective-serotonin-reuptake-inhibitors\" data-reference-link=\"\" aria-label=\"Reference 5: Chu A, Wadhwa R. (2022, May 8). Selective Serotonin Reuptake Inhibitors. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed May 24 2025.\" data-reference-number=\"5\">[5]</a></sup>; sudden, extreme mood changes, both highs, and lows (mood instability);  anxiety, <a class=\"article-inline-link\" href=\"https://www.mentalhealth.com/library/how-to-handle-bpd-rage\">inappropriate and excessive anger or rage</a>, impulsiveness; rejection sensitivity, and suicidal thoughts and behaviors⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#selective-serotonin-reuptake-inhibitors\" data-reference-link=\"\" aria-label=\"Reference 5: Chu A, Wadhwa R. (2022, May 8). Selective Serotonin Reuptake Inhibitors. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed May 24 2025.\" data-reference-number=\"5\">[5]</a></sup>.</p><p>Common side effects include dry mouth (xerostomia), sexual problems, sleep problems, changes in weight, anxiety, dizziness, headache, and gastrointestinal issues⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#selective-serotonin-reuptake-inhibitors\" data-reference-link=\"\" aria-label=\"Reference 5: Chu A, Wadhwa R. (2022, May 8). Selective Serotonin Reuptake Inhibitors. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed May 24 2025.\" data-reference-number=\"5\">[5]</a></sup>.</p><p>SSRIs can cause serious side effects such as electrical problems with the heart (QT interval), leading to a dangerous and fatal condition called Torsades de Pointes, an extremely rapid heart rhythm (tachycardia). </p><p>SSRIs can also impair the body’s ability to clot (hypercoagulation) and increase the risk of suicidal thoughts and actions in children and adults 25 and younger⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#selective-serotonin-reuptake-inhibitors\" data-reference-link=\"\" aria-label=\"Reference 5: Chu A, Wadhwa R. (2022, May 8). Selective Serotonin Reuptake Inhibitors. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed May 24 2025.\" data-reference-number=\"5\">[5]</a></sup>. </p><p>Three SSRIs that have been shown as effective in treating some symptoms of BPD include:</p><ul><li><strong><strong><a class=\"article-inline-link\" href=\"https://www.mentalhealth.com/library/fluoxetine-uses-dosage-side-effects\">Fluoxetine (Prozac)</a>: </strong></strong>Patients taking fluoxetine have shown minor improvement in anger, sensitivity to rejection, depressed mood, anxiety, impulsive behaviors, and affective symptoms⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#bridging-gap-between-education-appropriate-use-benzodiazepines-psychiatric-clinical\" data-reference-link=\"\" aria-label=\"Reference 8: Dell'Osso, B., Albert, U., Atti, A. R., Carmassi, C., Carrà, G., Cosci, F., Del Vecchio, V., Di Nicola, M., Ferrari, S., Goracci, A., Iasevoli, F., Luciano, M., Martinotti, G., Nanni, M. G., Nivoli, A., Pinna, F., Poloni, N., Pompili, M., Sampogna, G., Tarricone, I., … Fiorillo, A. (2015). Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatric disease and treatment, 11, 1885–1909. dovepress.com.\" data-reference-number=\"8\">[8]</a></sup>.</li><li><strong><strong><a class=\"article-inline-link\" href=\"https://www.mentalhealth.com/library/fluvoxamine-uses-dosage-side-effects\">Fluvoxamine (Luvox)</a>: </strong></strong>BPD patients taking fluvoxamine show minor improvements in affective instability (rapid and intense mood swings) but not impulsivity⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 15: Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor &amp; Francis.\" data-reference-number=\"15\">[15]</a></sup>.</li><li><strong><strong><a class=\"article-inline-link\" href=\"https://www.mentalhealth.com/library/paroxetine-uses-dosage-side-effects\">Paroxetine (Paxil)</a>: </strong></strong>Paroxetine may decrease suicidal behaviors but isn’t as effective in treating depression⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 15: Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor &amp; Francis.\" data-reference-number=\"15\">[15]</a></sup>.</li></ul><h3 id=\"monoamine-oxidase-inhibitors-maois\">Monoamine oxidase inhibitors (MAOIs)</h3><p>MAOIs block an enzyme called monoamine oxidase, which plays a role in mood⁠<sup class=\"citation-group\"><a href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-18\" class=\"article-citation\" data-reference-link=\"\" aria-label=\"Reference 18: Monoamine oxidase inhibitors (MAOIs). (n.d.). Mayo Clinic. Accessed October 10 2026.\" data-reference-number=\"18\">[18]</a></sup>. MAOIs are not considered the first choice in treating mental health disorders, but  are often prescribed after other antidepressants fail. This is due to them having an increased risk for dangerous, possibly fatal interactions with certain medications or foods⁠<sup class=\"citation-group\"><a href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-18\" class=\"article-citation\" data-reference-link=\"\" aria-label=\"Reference 18: Monoamine oxidase inhibitors (MAOIs). (n.d.). Mayo Clinic. Accessed October 10 2026.\" data-reference-number=\"18\">[18]</a></sup>.</p><p>Two MAOIs used to treat BPD symptoms include <a class=\"article-inline-link\" href=\"https://www.mentalhealth.com/library/phenelzine-uses-dosage-side-effects\">phenelzine (Nardil)</a> and tranylcypromine (Parnate) which may improve symptoms such as depression and impulsive aggression⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 15: Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor &amp; Francis.\" data-reference-number=\"15\">[15]</a></sup>.</p><h2 id=\"antipsychotics-neuroleptics\">Antipsychotics (neuroleptics)</h2><p>Antipsychotics, as a whole, have been associated with worsening the overall severity of borderline personality disorder⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 15: Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor &amp; Francis.\" data-reference-number=\"15\">[15]</a></sup>. Antipsychotic medications are frequently used for borderline personality disorder. They may effectively reduce impulsiveness, aggression, anxiety, and psychotic symptoms⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#borderline-personality-disorder-current-drug-treatments-future-prospects\" data-reference-link=\"\" aria-label=\"Reference 13: Olabi, B., &amp; Hall, J. (2010). Borderline personality disorder: current drug treatments and future prospects. Therapeutic advances in chronic disease, 1(2), 59–66. SAGE Journals. Accessed October 10 2026.\" data-reference-number=\"13\">[13]</a></sup>.</p><section aria-label=\"Subject matter expert\" class=\"article-expert article-expert-inline\" data-expert-kind=\"related\" data-expert-layout=\"standard\"><p class=\"article-bio-role\">Subject matter expert</p><div class=\"article-expert-identity\"><img alt=\"\" height=\"64\" loading=\"lazy\" src=\"https://www.mentalhealth.com/assets/optimized/5ffe249a46895c9a14f6074b.jpg\" width=\"64\" decoding=\"async\"><h2><a href=\"https://www.mentalhealth.com/people/simone-hoermann\">Simone Hoermann <span class=\"expert-credentials\">Ph.D.</span></a></h2></div><p class=\"article-expert-focus\">Personality disorders, anxiety, and depression</p><a class=\"profile-experience-link experience-button\" href=\"https://www.mentalhealth.com/people/simone-hoermann\">View experience</a></section><h3 id=\"first-generation-antipsychotics\">First generation antipsychotics</h3><p>First generation antipsychotics may improve some BPD symptoms, such as anger and impulsive aggressiveness. They pose risks of extrapyramidal symptoms (drug-induced movement disorder)⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan-2\" data-reference-link=\"\" aria-label=\"Reference 9: D'Souza RS, Hooten WM. (2022, August 1). Extrapyramidal Symptoms. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine.\" data-reference-number=\"9\">[9]</a></sup>, tardive dyskinesia (involuntary movements of tongue, lips, face, or body), and the deterioration of day to day functioning⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 15: Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor &amp; Francis.\" data-reference-number=\"15\">[15]</a></sup>. </p><ul><li><a class=\"article-inline-link\" href=\"https://www.mentalhealth.com/library/haloperidol-uses-dosage-side-effects\"><strong><strong>Haloperidol (Haldol)</strong></strong></a>: Haloperidol improves BPD symptoms of paranoia and anger, and may improve anxiety and affective symptoms. However, it may also worsen BPD symptoms overall, asbecause it can increase the risk of sedation, depression, and other side effects⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 15: Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor &amp; Francis.\" data-reference-number=\"15\">[15]</a></sup>. </li><li><a class=\"article-inline-link\" href=\"https://www.mentalhealth.com/library/loxapine-uses-dosage-side-effects\"><strong><strong>Loxapine (Loxitane)</strong></strong></a>: Whilst research findings are mostly inconclusive, some studies have found thatloxapine may improve BPD symptoms of depression and anger⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 15: Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor &amp; Francis.\" data-reference-number=\"15\">[15]</a></sup>.</li><li><strong><strong>Thiothixene (Navane)</strong></strong>: Whilst research findings are mostly inconclusive, some studies have found that thiothixene may improveany psychotic symptoms associated with BPD, such as paranoia, aggression, impulsivity and antisocial behavior.</li><li><strong><strong>Flupenthixol decanoate (Prolixin Decanoate) and flupenthixol depot (Fluanxol Depot): </strong></strong>These antipsychotics can improve symptoms of suicidal thoughts and behaviors⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 15: Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor &amp; Francis.\" data-reference-number=\"15\">[15]</a></sup>.</li></ul><h3 id=\"atypical-antipsychotics\">Atypical antipsychotics</h3><p>Atypical (second generation) antipsychotics tend to have fewer side effects and tend to be more effective at decreasing impulse aggression than first generation antipsychotics. </p><p>Psychotic symptoms are thought to be triggered by an overproduction of dopamine, Antipsychotics have been shown to reduce dopamine transmission, which can reduce these symptoms⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#antipsychotics-work-receptors-reality\" data-reference-link=\"\" aria-label=\"Reference 10: Kapur, S., Agid, O., Mizrahi, R., &amp; Li, M. (2006). How antipsychotics work-from receptors to reality. NeuroRx: the journal of the American Society for Experimental NeuroTherapeutics, 3(1), 10–21. Springer. Accessed October 10 2026.\" data-reference-number=\"10\">[10]</a></sup>.</p><p>Atypical antipsychotics used to treat BPD symptoms include:</p><ul><li>Olanzapine (Zyprexa): Studies of BPD symptoms have produced limited and mixed results. These medicines are not established treatments for BPD itself; prescribing requires an individualized assessment<sup class=\"citation-group\"><a class=\"article-citation\" data-reference-number=\"7\" data-reference-link=\"\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#current-clinical-psychopharmacology-borderline-personality-disorder\" aria-label=\"Reference 7: Del Casale, A., Bonanni, L., Bargagna, P., Novelli, F., Fiaschè, F., Paolini, M., Forcina, F., Anibaldi, G., Cortese, F. N., Iannuccelli, A., Adriani, B., Brugnoli, R., Girardi, P., Paris, J., &amp; Pompili, M. (2021). Current Clinical Psychopharmacology in Borderline Personality Disorder. Current neuropharmacology, 19(10), 1760–1779. eurekaselect.com. Accessed October 10 2026.\">[7]</a></sup>.</li><li><strong><strong>Aripiprazole (Abilify) </strong></strong><strong><strong>has been shown to </strong></strong>reduceimpulsive behavior, psychosis (loss of touch with reality), emotional instability, and interpersonal dysfunction⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 15: Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor &amp; Francis.\" data-reference-number=\"15\">[15]</a></sup>.</li><li><strong><strong><a class=\"article-inline-link\" href=\"https://www.mentalhealth.com/library/risperidone-use-doses-side-effects\">Risperidone (Risperdal)</a> </strong></strong>has been shown to reduce experiences of psychosis and the incidence of extrapyramidal adverse effects (drug-induced movement disorder)⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#personality-disorders-medication\" data-reference-link=\"\" aria-label=\"Reference 2: Bienefeld, D. (2021). Personality Disorders Medication. Medscape. emedicine.medscape.com.\" data-reference-number=\"2\">[2]</a></sup>.</li><li>Quetiapine (Seroquel): Evidence for improving BPD symptoms is limited and conflicting. These medicines are not established treatments for BPD itself; prescribing requires an individualized assessment<sup class=\"citation-group\"><a class=\"article-citation\" data-reference-number=\"7\" data-reference-link=\"\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#current-clinical-psychopharmacology-borderline-personality-disorder\" aria-label=\"Reference 7: Del Casale, A., Bonanni, L., Bargagna, P., Novelli, F., Fiaschè, F., Paolini, M., Forcina, F., Anibaldi, G., Cortese, F. N., Iannuccelli, A., Adriani, B., Brugnoli, R., Girardi, P., Paris, J., &amp; Pompili, M. (2021). Current Clinical Psychopharmacology in Borderline Personality Disorder. Current neuropharmacology, 19(10), 1760–1779. eurekaselect.com. Accessed October 10 2026.\">[7]</a></sup>.</li><li>Paliperidone: A small pilot study reported symptom improvements, but this does not establish effectiveness for BPD. These medicines are not established treatments for BPD itself; prescribing requires an individualized assessment<sup class=\"citation-group\"><a class=\"article-citation\" data-reference-number=\"7\" data-reference-link=\"\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#current-clinical-psychopharmacology-borderline-personality-disorder\" aria-label=\"Reference 7: Del Casale, A., Bonanni, L., Bargagna, P., Novelli, F., Fiaschè, F., Paolini, M., Forcina, F., Anibaldi, G., Cortese, F. N., Iannuccelli, A., Adriani, B., Brugnoli, R., Girardi, P., Paris, J., &amp; Pompili, M. (2021). Current Clinical Psychopharmacology in Borderline Personality Disorder. Current neuropharmacology, 19(10), 1760–1779. eurekaselect.com. Accessed October 10 2026.\">[7]</a></sup>.</li></ul><h2 id=\"mood-stabilizers-and-anticonvulsants\">Mood Stabilizers and Anticonvulsants</h2><p><a class=\"article-inline-link\" href=\"https://www.mentalhealth.com/library/mood-stabilizers\">Mood stabilizers</a> and anticonvulsants can be used to treat BPD symptoms such as mood instability, aggression, impulsivity, and overall day to day functioning⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 15: Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor &amp; Francis.\" data-reference-number=\"15\">[15]</a></sup>.</p><p>Mood stabilizers and anticonvulsants prescribed to treat BPD symptoms include:</p><ul><li><a class=\"article-inline-link\" href=\"https://www.mentalhealth.com/library/carbamazepine-uses-dosage-effects\"><strong><strong>Carbamazepine (Tegretol)</strong></strong></a>: Medication is not usually the primary treatment for borderline personality disorder. If a clinician proposes a medicine alongside psychotherapy, discuss the specific symptoms or co-occurring condition being targeted, the evidence, and potential side effects⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 15: Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor &amp; Francis.\" data-reference-number=\"15\">[15]</a><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#www-sciencedirect-com\" data-reference-link=\"\" aria-label=\"Reference 14: National Institute of Mental Health. (2025). Borderline Personality Disorder. National Institutes of Health. National Institute of Mental Health. Accessed October 10 2026.\" data-reference-number=\"14\">[14]</a></sup>.</li><li><a class=\"article-inline-link\" href=\"https://www.mentalhealth.com/library/divalproex-sodium-uses-dosage-side-effects\"><strong><strong>Divalproex sodium (Depakote)</strong></strong></a>: This medication improves interpersonal sensitivity, irritability, and aggression, mainly in people with high impulsive aggression⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 15: Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor &amp; Francis.\" data-reference-number=\"15\">[15]</a></sup>.</li><li><strong><strong><a class=\"article-inline-link\" href=\"https://www.mentalhealth.com/library/lamotrigine-uses-dosage-side-effects\">Lamotrigine target (Lamictal)</a>: </strong></strong>Lamotrigine has been shown to improve anger, mood instability, and impulsivity, but there is a small risk it can cause a potentially life-threatening rash and toxicity⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 15: Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor &amp; Francis.\" data-reference-number=\"15\">[15]</a></sup>.<strong><strong> </strong></strong></li><li><strong><strong><a class=\"article-inline-link\" href=\"https://www.mentalhealth.com/library/lithium-carbonate-uses-dosage-side-effects\">Lithium carbonate (Eskalith)</a>: </strong></strong>This has been shown to improvemood instability and may improve overall functioning, but data is limited⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 15: Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor &amp; Francis.\" data-reference-number=\"15\">[15]</a></sup>.<strong><strong> </strong></strong></li><li><strong><strong>Topiramate (Topamax): </strong></strong>This has been shown to improve anger, anxiety, and problems maintaining relationships. Some peoplewith BPD have reported that it improves their quality of life, but it is associated with weight loss, which may be a problem for people with eating disorders⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 15: Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor &amp; Francis.\" data-reference-number=\"15\">[15]</a></sup>.</li></ul><p>Pregnancy-related medication risks require individual specialist review. Tell your prescriber if you are pregnant, planning pregnancy, or breastfeeding<sup class=\"citation-group\"><a class=\"article-citation\" data-reference-number=\"20\" data-reference-link=\"\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-20\" aria-label=\"Reference 20: Borderline personality disorder: management. (n.d.). pharmaceutical-journal.com. Accessed October 10 2026.\">[20]</a></sup>.</p><h2 id=\"anxiolytics\">Anxiolytics</h2><p>Anxiolytics are medications used to treat anxiety and other mental health conditions such as panic disorders and insomnia⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#anxiolytics-sedative-hypnotics-toxicity\" data-reference-link=\"\" aria-label=\"Reference 17: Simone CG, Bobrin BD. (2022, August 29). Anxiolytics and Sedative-Hypnotics Toxicity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine.\" data-reference-number=\"17\">[17]</a></sup>. anxiolytic drugs stimulate GABA receptors, which creates calming effects⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#dietary-botanical-anxiolytics\" data-reference-link=\"\" aria-label=\"Reference 1: Alramadhan, E., Hanna, M. S., Hanna, M. S., Goldstein, T. A., Avila, S. M., &amp; Weeks, B. S. (2012). Dietary and botanical anxiolytics. Medical science monitor: international medical journal of experimental and clinical research, 18(4), RA40–RA48. medscimonit.com. Accessed October 10 2026.\" data-reference-number=\"1\">[1]</a></sup>.</p><p>The brain can grow accustomed to anxiety medications, which reduce their effectiveness and may require higher doses or medication changes⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#dietary-botanical-anxiolytics\" data-reference-link=\"\" aria-label=\"Reference 1: Alramadhan, E., Hanna, M. S., Hanna, M. S., Goldstein, T. A., Avila, S. M., &amp; Weeks, B. S. (2012). Dietary and botanical anxiolytics. Medical science monitor: international medical journal of experimental and clinical research, 18(4), RA40–RA48. medscimonit.com. Accessed October 10 2026.\" data-reference-number=\"1\">[1]</a></sup>.Anxiety medications may be misused or abused, which can have life-threatening consequences⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#anxiolytics-sedative-hypnotics-toxicity\" data-reference-link=\"\" aria-label=\"Reference 17: Simone CG, Bobrin BD. (2022, August 29). Anxiolytics and Sedative-Hypnotics Toxicity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine.\" data-reference-number=\"17\">[17]</a></sup>. </p><p>Benzodiazepines are commonly used to treat anxiety, insomnia, seizures, spastic disorders, and agitation and may be used to treat anxiety in BPD patients⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan\" data-reference-link=\"\" aria-label=\"Reference 3: Bounds CG, Nelson VL. (2021, November 14). Benzodiazepines. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed January 12 2023.\" data-reference-number=\"3\">[3]</a></sup>. </p><p>However, the use of anxiolytics and sedatives to treat BPD should be closely monitored, since they can cause disinhibition, which can be a problem for people with BPD since they can be impulsive⁠<sup class=\"citation-group\"><a href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-20\" class=\"article-citation\" data-reference-link=\"\" aria-label=\"Reference 20: Borderline personality disorder: management. (n.d.). pharmaceutical-journal.com. Accessed October 10 2026.\" data-reference-number=\"20\">[20]</a></sup>. </p><p>Common benzodiazepines include: </p><ul><li><a class=\"article-inline-link\" href=\"https://www.mentalhealth.com/library/lorazepam-uses-dosage-side-effects\"><strong><strong>Lorazepam (Ativan)</strong></strong></a>: Lorazepam is a sedative that creates a calming effect. It can be helpful if used for a short time for crisis management⁠<sup class=\"citation-group\"><a href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-20\" class=\"article-citation\" data-reference-link=\"\" aria-label=\"Reference 20: Borderline personality disorder: management. (n.d.). pharmaceutical-journal.com. Accessed October 10 2026.\" data-reference-number=\"20\">[20]</a></sup>.</li><li><a class=\"article-inline-link\" href=\"https://www.mentalhealth.com/library/clonazepam-uses-dosage-side-effects\"><strong><strong>Clonazepam (Klonopin)</strong></strong></a>: Clonazepam is used to treat panic disorder. Clonazepam may improve impulsivity and anxiety, but there is limited data available on its effectiveness⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#bridging-gap-between-education-appropriate-use-benzodiazepines-psychiatric-clinical\" data-reference-link=\"\" aria-label=\"Reference 8: Dell'Osso, B., Albert, U., Atti, A. R., Carmassi, C., Carrà, G., Cosci, F., Del Vecchio, V., Di Nicola, M., Ferrari, S., Goracci, A., Iasevoli, F., Luciano, M., Martinotti, G., Nanni, M. G., Nivoli, A., Pinna, F., Poloni, N., Pompili, M., Sampogna, G., Tarricone, I., … Fiorillo, A. (2015). Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatric disease and treatment, 11, 1885–1909. dovepress.com.\" data-reference-number=\"8\">[8]</a></sup>.</li><li><a class=\"article-inline-link\" href=\"https://www.mentalhealth.com/library/alprazolam-xanax-uses-dosage-side-effects\"><strong><strong>Alprazolam (Xanax)</strong></strong></a>: Alprazolam is commonly used to treat anxiety and panic disorders. Alprazolam, like clonazepam, may improve impulsivity and anxiety, but there is limited data available on its effectiveness, and some data shows it might lower inhibition and control. Since BPD can cause impulsivity, this could be problematic, especially if suicidal thoughts and self-harming behaviors are present⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#bridging-gap-between-education-appropriate-use-benzodiazepines-psychiatric-clinical\" data-reference-link=\"\" aria-label=\"Reference 8: Dell'Osso, B., Albert, U., Atti, A. R., Carmassi, C., Carrà, G., Cosci, F., Del Vecchio, V., Di Nicola, M., Ferrari, S., Goracci, A., Iasevoli, F., Luciano, M., Martinotti, G., Nanni, M. G., Nivoli, A., Pinna, F., Poloni, N., Pompili, M., Sampogna, G., Tarricone, I., … Fiorillo, A. (2015). Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatric disease and treatment, 11, 1885–1909. dovepress.com.\" data-reference-number=\"8\">[8]</a></sup>.</li><li><a class=\"article-inline-link\" href=\"https://www.mentalhealth.com/library/diazepam-uses-dosage-side-effects\"><strong><strong>Diazepam (Valium)</strong></strong></a>: Diazepam has the same calming effect lorazepam and other benzodiazepines have. It can be helpful if used for a short period and to help manage symptoms when crisis management is necessary, such as for a short period while a patient is an inpatient⁠<sup class=\"citation-group\"><a href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-20\" class=\"article-citation\" data-reference-link=\"\" aria-label=\"Reference 20: Borderline personality disorder: management. (n.d.). pharmaceutical-journal.com. Accessed October 10 2026.\" data-reference-number=\"20\">[20]</a></sup>.</li></ul><p>Using benzodiazepines requires well-coordinated and planned treatment approaches, such as using time-limited prescriptions⁠<sup class=\"citation-group\"><a href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-20\" class=\"article-citation\" data-reference-link=\"\" aria-label=\"Reference 20: Borderline personality disorder: management. (n.d.). pharmaceutical-journal.com. Accessed October 10 2026.\" data-reference-number=\"20\">[20]</a></sup>.</p><p>Common side effects of benzodiazepines include⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan\" data-reference-link=\"\" aria-label=\"Reference 3: Bounds CG, Nelson VL. (2021, November 14). Benzodiazepines. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed January 12 2023.\" data-reference-number=\"3\">[3]</a></sup>: </p><ul><li>Headache</li><li>Nausea or vomiting</li><li>Diarrhea</li><li>Problems breathing or shortness of breath</li><li>Respiratory arrest (not breathing)</li><li>Loss of consciousness</li><li>Tremors (involuntary shaking or movements)⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan-source\" data-reference-link=\"\" aria-label=\"Reference 4: Chapman J, Jamil RT, Fleisher C. (2022, May 2). Borderline Personality Disorder. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed June 6 2023.\" data-reference-number=\"4\">[4]</a></sup></li></ul><p>Benzodiazepines can cause more severe side effects, such as angle-closure glaucoma, caused by intraocular eye pressure, which compresses the optical nerve at the back of the eye⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan\" data-reference-link=\"\" aria-label=\"Reference 3: Bounds CG, Nelson VL. (2021, November 14). Benzodiazepines. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed January 12 2023.\" data-reference-number=\"3\">[3]</a></sup>. Benzodiazepines should be used sparingly in pregnant and breastfeeding women, due to some potential risks to the baby⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan\" data-reference-link=\"\" aria-label=\"Reference 3: Bounds CG, Nelson VL. (2021, November 14). Benzodiazepines. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed January 12 2023.\" data-reference-number=\"3\">[3]</a></sup>.</p><h2 id=\"other-medications\">Other medications</h2><ul><li><strong><strong>Channel blockers </strong></strong>can regulate the overactivity of the neurotransmitter glutamate⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan\" data-reference-link=\"\" aria-label=\"Reference 3: Bounds CG, Nelson VL. (2021, November 14). Benzodiazepines. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed January 12 2023.\" data-reference-number=\"3\">[3]</a></sup>. One study showed memantine added to another typical drug treatment improved BPD symptoms⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#current-clinical-psychopharmacology-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 7: Del Casale, A., Bonanni, L., Bargagna, P., Novelli, F., Fiaschè, F., Paolini, M., Forcina, F., Anibaldi, G., Cortese, F. N., Iannuccelli, A., Adriani, B., Brugnoli, R., Girardi, P., Paris, J., &amp; Pompili, M. (2021). Current Clinical Psychopharmacology in Borderline Personality Disorder. Current neuropharmacology, 19(10), 1760–1779. eurekaselect.com. Accessed October 10 2026.\" data-reference-number=\"7\">[7]</a></sup>.</li><li><strong><strong>Opioid antagonists </strong></strong>have been shown to reduce some self-harm behaviors⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#current-clinical-psychopharmacology-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 7: Del Casale, A., Bonanni, L., Bargagna, P., Novelli, F., Fiaschè, F., Paolini, M., Forcina, F., Anibaldi, G., Cortese, F. N., Iannuccelli, A., Adriani, B., Brugnoli, R., Girardi, P., Paris, J., &amp; Pompili, M. (2021). Current Clinical Psychopharmacology in Borderline Personality Disorder. Current neuropharmacology, 19(10), 1760–1779. eurekaselect.com. Accessed October 10 2026.\" data-reference-number=\"7\">[7]</a></sup>.</li><li><strong><strong>Neuropeptides </strong></strong>such as oxytocin, opioids, and vasopressin may help with BPD symptoms⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 15: Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor &amp; Francis.\" data-reference-number=\"15\">[15]</a></sup>. The neuropeptide oxytocin has been shown to lessen threat sensitivity in patients with BPD and studies suggest that it may improve interpersonal dysfunction⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#oxytocin-normalizes-approach-avoidance-behavior-women-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 16: Schneider, I., Boll, S., Volman, I., Roelofs, K., Spohn, A., Herpertz, S. C., &amp; Bertsch, K. (2020). Oxytocin Normalizes Approach-Avoidance Behavior in Women With Borderline Personality Disorder. Frontiers in psychiatry, 11, 120. Frontiers. Accessed October 10 2026.\" data-reference-number=\"16\">[16]</a></sup>.</li><li><strong><strong>Omega-3 fatty acids</strong></strong><strong><strong> </strong></strong>have shown to improve symptoms of BPD, especially for impulsivity and mood dysregulation. Omega-3 fatty acids may be used in combination with another therapy⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#marine-omega-3-fatty-acid-supplementation-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 11: Karaszewska, D. M., Ingenhoven, T., &amp; Mocking, R. J. T. (2021). Marine Omega-3 Fatty Acid Supplementation for Borderline Personality Disorder: A Meta-Analysis. The Journal of clinical psychiatry, 82(3), 20r13613. psychiatrist.com. Accessed October 10 2026.\" data-reference-number=\"11\">[11]</a></sup>. </li><li><strong>ORY-2001 (Vafidemstat)</strong> is being evaluated in clinical studies for treating central nervous system (CNS) diseases such as Alzheimer's Disease (AD) and Borderline Personality Disorder⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#biological-therapeutic-role-lsd1-alzheimer-s-diseases\" data-reference-link=\"\" aria-label=\"Reference 12: Li, Y., Zhao, Y., Li, X., Zhai, L., Zheng, H., Yan, Y., Fu, Q., Ma, J., Fu, H., Zhang, Z., &amp; Li, Z. (2022). Biological and therapeutic role of LSD1 in Alzheimer's diseases. Frontiers in pharmacology, 13, 1020556. Frontiers. Accessed October 10 2026.\" data-reference-number=\"12\">[12]</a></sup>.</li></ul><p>Preliminary studies have shown a significant reduction in neuroinflammation after six months and 12 months of treatment. ORY-2001<strong><strong> </strong></strong>may reduce cognitive deterioration and normalize genes related to cognitive function, neuroplasticity, and memory⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#biological-therapeutic-role-lsd1-alzheimer-s-diseases\" data-reference-link=\"\" aria-label=\"Reference 12: Li, Y., Zhao, Y., Li, X., Zhai, L., Zheng, H., Yan, Y., Fu, Q., Ma, J., Fu, H., Zhang, Z., &amp; Li, Z. (2022). Biological and therapeutic role of LSD1 in Alzheimer's diseases. Frontiers in pharmacology, 13, 1020556. Frontiers. Accessed October 10 2026.\" data-reference-number=\"12\">[12]</a></sup>. The first assessment on humans has proven it is safe and well tolerated⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#biological-therapeutic-role-lsd1-alzheimer-s-diseases\" data-reference-link=\"\" aria-label=\"Reference 12: Li, Y., Zhao, Y., Li, X., Zhai, L., Zheng, H., Yan, Y., Fu, Q., Ma, J., Fu, H., Zhang, Z., &amp; Li, Z. (2022). Biological and therapeutic role of LSD1 in Alzheimer's diseases. Frontiers in pharmacology, 13, 1020556. Frontiers. Accessed October 10 2026.\" data-reference-number=\"12\">[12]</a></sup>.</p><h2 id=\"other-bpd-treatments\">Other BPD treatments</h2><p>Several types of psychotherapy have been shown as effective in the treatment and management of BPD. </p><p>The most effective approaches include:</p><ul><li><strong><strong>Dialectical behavior therapy (DBT)</strong></strong> DBT was developed using Cognitive behavioral therapy (CBT), for the treatment of BPD. Many therapists view DBT as the ‘gold standard’ therapeutic approach for BPD management. According to DBT, people with BPD can learn techniques that focus on interpersonal effectiveness, distress tolerance, mindfulness, and emotion regulation⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#works-treatment-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 6: Choi-Kain, L. W., Finch, E. F., Masland, S. R., Jenkins, J. A., &amp; Unruh, B. T. (2017). What Works in the Treatment of Borderline Personality Disorder. Current behavioral neuroscience reports, 4(1), 21–30. Springer. Accessed October 10 2026.\" data-reference-number=\"6\">[6]</a></sup>.</li><li><strong><strong>Mentalization-Based Treatment (MBT) </strong></strong>focuses on strengthening the BPD patient’s capacity to mentally process information and understand their own and others' mental states, such as thoughts, feelings, beliefs, and behaviors, to help them make sense of them⁠<sup class=\"citation-group\"><a class=\"article-citation\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#works-treatment-borderline-personality-disorder\" data-reference-link=\"\" aria-label=\"Reference 6: Choi-Kain, L. W., Finch, E. F., Masland, S. R., Jenkins, J. A., &amp; Unruh, B. T. (2017). What Works in the Treatment of Borderline Personality Disorder. Current behavioral neuroscience reports, 4(1), 21–30. Springer. Accessed October 10 2026.\" data-reference-number=\"6\">[6]</a></sup>.</li></ul></article><div class=\"article-endmatter\"><section class=\"article-sources\" data-reference-list=\"\" data-reference-style=\"author-date-title-source\" data-source-references=\"\" id=\"references\"><h2 id=\"references-2\">References</h2><ol><li id=\"dietary-botanical-anxiolytics\" value=\"1\" data-reference-number=\"1\" data-reference-format=\"393\">Alramadhan, E., Hanna, M. S., Hanna, M. S., Goldstein, T. A., Avila, S. M., &amp; Weeks, B. S. (2012). <em class=\"reference-title\">Dietary and botanical anxiolytics.</em> Medical science monitor: international medical journal of experimental and clinical research, 18(4), RA40–RA48. <a href=\"https://medscimonit.com/abstract/full/idArt/882608?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">medscimonit.com</a>. Accessed October 10 2026.</li><li id=\"personality-disorders-medication\" value=\"2\" data-reference-number=\"2\" data-reference-format=\"393\">Bienefeld, D. (2021). <em class=\"reference-title\">Personality Disorders Medication.</em> Medscape. <a href=\"https://emedicine.medscape.com/article/294307-medication?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">emedicine.medscape.com</a>.</li><li id=\"treasure-island-fl-statpearls-publishing-2022-jan\" value=\"3\" data-reference-number=\"3\" data-reference-format=\"393\">Bounds CG, Nelson VL. (2021, November 14). <em class=\"reference-title\">Benzodiazepines.</em> In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK470159/?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">National Library of Medicine</a>. Accessed January 12 2023.</li><li id=\"treasure-island-fl-statpearls-publishing-2022-jan-source\" value=\"4\" data-reference-number=\"4\" data-reference-format=\"393\">Chapman J, Jamil RT, Fleisher C. (2022, May 2). <em class=\"reference-title\">Borderline Personality Disorder.</em> In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK430883/?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">National Library of Medicine</a>. Accessed June 6 2023.</li><li id=\"selective-serotonin-reuptake-inhibitors\" value=\"5\" data-reference-number=\"5\" data-reference-format=\"393\">Chu A, Wadhwa R. (2022, May 8). <em class=\"reference-title\">Selective Serotonin Reuptake Inhibitors.</em> In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK554406/?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">National Library of Medicine</a>. Accessed May 24 2025.</li><li id=\"works-treatment-borderline-personality-disorder\" value=\"6\" data-reference-number=\"6\" data-reference-format=\"393\">Choi-Kain, L. W., Finch, E. F., Masland, S. R., Jenkins, J. A., &amp; Unruh, B. T. (2017). <em class=\"reference-title\">What Works in the Treatment of Borderline Personality Disorder.</em> Current behavioral neuroscience reports, 4(1), 21–30. <a href=\"https://link.springer.com/article/10.1007/s40473-017-0103-z?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">Springer</a>. Accessed October 10 2026.</li><li id=\"current-clinical-psychopharmacology-borderline-personality-disorder\" value=\"7\" data-reference-number=\"7\" data-reference-format=\"393\">Del Casale, A., Bonanni, L., Bargagna, P., Novelli, F., Fiaschè, F., Paolini, M., Forcina, F., Anibaldi, G., Cortese, F. N., Iannuccelli, A., Adriani, B., Brugnoli, R., Girardi, P., Paris, J., &amp; Pompili, M. (2021). <em class=\"reference-title\">Current Clinical Psychopharmacology in Borderline Personality Disorder.</em> Current neuropharmacology, 19(10), 1760–1779. <a href=\"https://www.eurekaselect.com/article/116088?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">eurekaselect.com</a>. Accessed October 10 2026.</li><li id=\"bridging-gap-between-education-appropriate-use-benzodiazepines-psychiatric-clinical\" value=\"8\" data-reference-number=\"8\" data-reference-format=\"393\">Dell'Osso, B., Albert, U., Atti, A. R., Carmassi, C., Carrà, G., Cosci, F., Del Vecchio, V., Di Nicola, M., Ferrari, S., Goracci, A., Iasevoli, F., Luciano, M., Martinotti, G., Nanni, M. G., Nivoli, A., Pinna, F., Poloni, N., Pompili, M., Sampogna, G., Tarricone, I., … Fiorillo, A. (2015). <em class=\"reference-title\">Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice.</em> Neuropsychiatric disease and treatment, 11, 1885–1909. <a href=\"http://www.dovepress.com/bridging-the-gap-between-education-and-appropriate-use-of-benzodiazepi-peer-reviewed-article-NDT?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">dovepress.com</a>.</li><li id=\"treasure-island-fl-statpearls-publishing-2022-jan-2\" value=\"9\" data-reference-number=\"9\" data-reference-format=\"393\">D'Souza RS, Hooten WM. (2022, August 1). <em class=\"reference-title\">Extrapyramidal Symptoms.</em> In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK534115/?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">National Library of Medicine</a>.</li><li id=\"antipsychotics-work-receptors-reality\" value=\"10\" data-reference-number=\"10\" data-reference-format=\"393\">Kapur, S., Agid, O., Mizrahi, R., &amp; Li, M. (2006). <em class=\"reference-title\">How antipsychotics work-from receptors to reality.</em> NeuroRx: the journal of the American Society for Experimental NeuroTherapeutics, 3(1), 10–21. <a href=\"https://link.springer.com/article/10.1016/j.nurx.2005.12.003?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">Springer</a>. Accessed October 10 2026.</li><li id=\"marine-omega-3-fatty-acid-supplementation-borderline-personality-disorder\" value=\"11\" data-reference-number=\"11\" data-reference-format=\"393\">Karaszewska, D. M., Ingenhoven, T., &amp; Mocking, R. J. T. (2021). <em class=\"reference-title\">Marine Omega-3 Fatty Acid Supplementation for Borderline Personality Disorder: A Meta-Analysis.</em> The Journal of clinical psychiatry, 82(3), 20r13613. <a href=\"https://www.psychiatrist.com/jcp/marine-omega-3-fatty-acid-supplementation-borderline-personality-disorder-meta-analysis/?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">psychiatrist.com</a>. Accessed October 10 2026.</li><li id=\"biological-therapeutic-role-lsd1-alzheimer-s-diseases\" value=\"12\" data-reference-number=\"12\" data-reference-format=\"393\">Li, Y., Zhao, Y., Li, X., Zhai, L., Zheng, H., Yan, Y., Fu, Q., Ma, J., Fu, H., Zhang, Z., &amp; Li, Z. (2022). <em class=\"reference-title\">Biological and therapeutic role of LSD1 in Alzheimer's diseases.</em> Frontiers in pharmacology, 13, 1020556. <a href=\"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.1020556/full?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">Frontiers</a>. Accessed October 10 2026.</li><li id=\"borderline-personality-disorder-current-drug-treatments-future-prospects\" value=\"13\" data-reference-number=\"13\" data-reference-format=\"393\">Olabi, B., &amp; Hall, J. (2010). <em class=\"reference-title\">Borderline personality disorder: current drug treatments and future prospects.</em> Therapeutic advances in chronic disease, 1(2), 59–66. <a href=\"https://journals.sagepub.com/doi/10.1177/2040622310368455?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">SAGE Journals</a>. Accessed October 10 2026.</li><li id=\"www-sciencedirect-com\" value=\"14\" data-reference-number=\"14\" data-reference-format=\"393\">National Institute of Mental Health. (2025). <em class=\"reference-title\">Borderline Personality Disorder.</em> National Institutes of Health. <a href=\"https://www.nimh.nih.gov/health/publications/borderline-personality-disorder?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">National Institute of Mental Health</a>. Accessed October 10 2026.</li><li id=\"psychopharmacologic-treatment-borderline-personality-disorder\" value=\"15\" data-reference-number=\"15\" data-reference-format=\"393\">Ripoll L. H. (2013). <em class=\"reference-title\">Psychopharmacologic treatment of borderline personality disorder.</em> Dialogues in clinical neuroscience, 15(2), 213–224. <a href=\"https://www.tandfonline.com/doi/full/10.31887/DCNS.2013.15.2/lripoll?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">Taylor &amp; Francis</a>.</li><li id=\"oxytocin-normalizes-approach-avoidance-behavior-women-borderline-personality-disorder\" value=\"16\" data-reference-number=\"16\" data-reference-format=\"393\">Schneider, I., Boll, S., Volman, I., Roelofs, K., Spohn, A., Herpertz, S. C., &amp; Bertsch, K. (2020). <em class=\"reference-title\">Oxytocin Normalizes Approach-Avoidance Behavior in Women With Borderline Personality Disorder.</em> Frontiers in psychiatry, 11, 120. <a href=\"https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2020.00120/full?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">Frontiers</a>. Accessed October 10 2026.</li><li id=\"anxiolytics-sedative-hypnotics-toxicity\" value=\"17\" data-reference-number=\"17\" data-reference-format=\"393\">Simone CG, Bobrin BD. (2022, August 29). <em class=\"reference-title\">Anxiolytics and Sedative-Hypnotics Toxicity.</em> In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK562309/?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">National Library of Medicine</a>.</li><li id=\"verified-source-370-18\" value=\"18\" data-reference-number=\"18\" data-reference-format=\"393\"><em class=\"reference-title\">Monoamine oxidase inhibitors (MAOIs).</em> (n.d.). <a href=\"https://www.mayoclinic.org/diseases-conditions/depression/in-depth/maois/art-20043992?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">Mayo Clinic</a>. Accessed October 10 2026.</li><li id=\"verified-source-370-19\" value=\"19\" data-reference-number=\"19\" data-reference-format=\"393\"><em class=\"reference-title\">Pharmacological interventions for personality disorders.</em> (n.d.). <a href=\"https://www.nice.org.uk/guidance/qs88/chapter/Quality-statement-4-Pharmacological-interventions?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">nice.org.uk</a>. Accessed October 10 2026.</li><li id=\"verified-source-370-20\" value=\"20\" data-reference-number=\"20\" data-reference-format=\"393\"><em class=\"reference-title\">Borderline personality disorder: management.</em> (n.d.). <a href=\"https://pharmaceutical-journal.com/article/ld/borderline-personality-disorder-management?utm_medium=referral&amp;utm_campaign=libra&amp;utm_content=external_resource&amp;utm_id=site-library-medication-for-borderline-personality-disorder&amp;utm_source=mentalhealth.com\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"reference-source\">pharmaceutical-journal.com</a>. Accessed October 10 2026.</li></ol></section><section class=\"article-medical article-panel\"><h2 id=\"medical-content\">Medical Content</h2><p><a href=\"https://www.mentalhealth.com/clinical-affairs\">The Clinical Affairs Team</a> at MentalHealth.com is a dedicated group of medical professionals with diverse and extensive clinical experience. They actively contribute to the development of content, products, and services, and meticulously review all medical material before publication to ensure accuracy and alignment with current research and conversations in mental health. For more information, please visit the <a href=\"https://www.mentalhealth.com/publishing/editorial-policy\">Editorial Policy</a>.</p></section><section class=\"article-about article-panel\"><h2 id=\"about-mentalhealth-com\">About MentalHealth.com</h2><p>MentalHealth.com helps people understand themselves, build healthier relationships, and access the right care. We bring together mental health education, diagnostics, and care management to support well-being throughout every phase of life.</p><div class=\"article-contributors\"><section class=\"article-bio\"><img alt=\"\" height=\"64\" loading=\"lazy\" src=\"https://www.mentalhealth.com/assets/optimized/a31666132215697b750001da.webp\" width=\"64\" decoding=\"async\"><div><p class=\"article-bio-role\">Author</p><h3 id=\"jill-sensenig\"><a href=\"https://www.mentalhealth.com/people/jill-sensenig\">Jill Sensenig</a></h3><p class=\"article-bio-credentials\">MBA</p><p>Jill Sensenig is a medical writer with 16+ years experience in the healthcare industry as a writer, editor, and author.</p><dl><div><dt>Published</dt><dd><time datetime=\"2023-01-12T11:53:33Z\">January 12, 2023</time></dd></div><div><dt>Updated</dt><dd><time datetime=\"2025-08-27T10:56:54Z\">August 27, 2025</time></dd></div></dl></div></section><section class=\"article-bio\"><img alt=\"\" height=\"64\" loading=\"lazy\" src=\"https://www.mentalhealth.com/assets/optimized/695fdf81224f51c976460925.webp\" width=\"64\" decoding=\"async\"><div><p class=\"article-bio-role\">Medical Reviewer</p><h3 id=\"tayler-hackett\"><a href=\"https://www.mentalhealth.com/people/tayler-hackett\">Tayler Hackett</a></h3><p class=\"article-bio-credentials\">BSc, PGCert</p><p>Talyer Hackett is a medical writer and researcher with 10+ years of experience, holding B.A. in Psychology from the University of Liverpool.</p><dl><div><dt>Reviewed</dt><dd><time datetime=\"2023-01-12\">January 12, 2023</time></dd></div></dl></div></section></div></section><section aria-label=\"Related community\" class=\"article-topic-community article-topic-community-end\"><img alt=\"\" class=\"topic-community-banner\" height=\"1536\" loading=\"lazy\" src=\"https://www.mentalhealth.com/assets/optimized/2f9e9d1a0710aab4fb0058aa.webp\" width=\"1024\" decoding=\"async\"><p class=\"topic-community-label\">Related community</p><h2>Personality Disorders</h2><p>Explore perspectives on personality disorders, everyday experiences, and relationships.</p><a href=\"https://www.mentalhealth.com/community/personality-disorders\">Explore community</a></section></div></div><aside aria-label=\"Article navigation and related information\" class=\"article-sidebar\" data-bounded-rail=\"\" tabindex=\"0\"><details class=\"article-contents\" data-expanded=\"false\" data-scrolled-past=\"false\" data-section-preview=\"3\" open=\"\"><summary><strong>Table of contents</strong><span aria-hidden=\"true\"></span><small data-current-section=\"\">Choose a section</small></summary><nav aria-label=\"Article contents\"><ol id=\"article-section-list\"><li><a aria-label=\"Antidepressants\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#antidepressants\" title=\"Antidepressants\">Antidepressants</a></li><li><a aria-label=\"Antipsychotics (neuroleptics)\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#antipsychotics-neuroleptics\" title=\"Antipsychotics (neuroleptics)\">Antipsychotics (neuroleptics)</a></li><li><a aria-label=\"Mood Stabilizers and Anticonvulsants\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#mood-stabilizers-and-anticonvulsants\" title=\"Mood Stabilizers and Anticonvulsants\">Mood Stabilizers and Anticonvulsants</a></li><li><a aria-label=\"Anxiolytics\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#anxiolytics\" title=\"Anxiolytics\">Anxiolytics</a></li><li><a aria-label=\"Other medications\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#other-medications\" title=\"Other medications\">Other medications</a></li><li><a aria-label=\"Other BPD treatments\" href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#other-bpd-treatments\" title=\"Other BPD treatments\">Other BPD treatments</a></li></ol><button aria-controls=\"article-section-list\" aria-expanded=\"false\" class=\"article-sections-toggle\" data-sections-toggle=\"\" type=\"button\">View more</button></nav></details></aside></div></div></div></div>","text":"HomeLibraryPersonality DisordersMedications for Borderline Personality DisorderMedications for Borderline Personality DisorderWritten by Jill SensenigMedically reviewed by Tayler HackettPublished on January 12, 2023 · Updated on August 27, 2025There are no medications specifically approved by the U.S. Food and Drug Administration (FDA) to treat borderline personality disorder (BPD)[4]. However, prescription medications are often used to manage the symptoms that occur with BPD, such as anxiety, sleep problems, depression, aggression, mood swings, impulsivity, or psychotic symptoms⁠[4]. This includes medications such as antidepressants, antipsychotics, mood stabilizers, and anxiolytics (anxiety medications).Key takeawaysMedication is sometimes used to target particular symptoms or coexisting conditions in borderline personality disorder.Potential benefits need to be weighed against adverse effects, limited evidence, and risks such as disinhibition with some sedatives.Structured psychotherapy remains central, with approaches such as Dialectical behavior therapy (DBT) and mentalization-based treatment developing coping and relationship skills.AntidepressantsAntidepressants may be prescribed for a co-occurring condition such as depression or an anxiety disorder; they do not replace psychological treatment for BPD[19].Serotonin reuptake inhibitors (SSRIs)SSRIs increase the level of serotonin in the brain and are used to treat BPD symptoms such as depression⁠[5]; sudden, extreme mood changes, both highs, and lows (mood instability); anxiety, inappropriate and excessive anger or rage, impulsiveness; rejection sensitivity, and suicidal thoughts and behaviors⁠[5].Common side effects include dry mouth (xerostomia), sexual problems, sleep problems, changes in weight, anxiety, dizziness, headache, and gastrointestinal issues⁠[5].SSRIs can cause serious side effects such as electrical problems with the heart (QT interval), leading to a dangerous and fatal condition called Torsades de Pointes, an extremely rapid heart rhythm (tachycardia). SSRIs can also impair the body’s ability to clot (hypercoagulation) and increase the risk of suicidal thoughts and actions in children and adults 25 and younger⁠[5]. Three SSRIs that have been shown as effective in treating some symptoms of BPD include:Fluoxetine (Prozac): Patients taking fluoxetine have shown minor improvement in anger, sensitivity to rejection, depressed mood, anxiety, impulsive behaviors, and affective symptoms⁠[8].Fluvoxamine (Luvox): BPD patients taking fluvoxamine show minor improvements in affective instability (rapid and intense mood swings) but not impulsivity⁠[15].Paroxetine (Paxil): Paroxetine may decrease suicidal behaviors but isn’t as effective in treating depression⁠[15].Monoamine oxidase inhibitors (MAOIs)MAOIs block an enzyme called monoamine oxidase, which plays a role in mood⁠[18]. MAOIs are not considered the first choice in treating mental health disorders, but are often prescribed after other antidepressants fail. This is due to them having an increased risk for dangerous, possibly fatal interactions with certain medications or foods⁠[18].Two MAOIs used to treat BPD symptoms include phenelzine (Nardil) and tranylcypromine (Parnate) which may improve symptoms such as depression and impulsive aggression⁠[15].Antipsychotics (neuroleptics)Antipsychotics, as a whole, have been associated with worsening the overall severity of borderline personality disorder⁠[15]. Antipsychotic medications are frequently used for borderline personality disorder. They may effectively reduce impulsiveness, aggression, anxiety, and psychotic symptoms⁠[13].Subject matter expertSimone Hoermann Ph.D.Personality disorders, anxiety, and depressionView experienceFirst generation antipsychoticsFirst generation antipsychotics may improve some BPD symptoms, such as anger and impulsive aggressiveness. They pose risks of extrapyramidal symptoms (drug-induced movement disorder)⁠[9], tardive dyskinesia (involuntary movements of tongue, lips, face, or body), and the deterioration of day to day functioning⁠[15]. Haloperidol (Haldol): Haloperidol improves BPD symptoms of paranoia and anger, and may improve anxiety and affective symptoms. However, it may also worsen BPD symptoms overall, asbecause it can increase the risk of sedation, depression, and other side effects⁠[15]. Loxapine (Loxitane): Whilst research findings are mostly inconclusive, some studies have found thatloxapine may improve BPD symptoms of depression and anger⁠[15].Thiothixene (Navane): Whilst research findings are mostly inconclusive, some studies have found that thiothixene may improveany psychotic symptoms associated with BPD, such as paranoia, aggression, impulsivity and antisocial behavior.Flupenthixol decanoate (Prolixin Decanoate) and flupenthixol depot (Fluanxol Depot): These antipsychotics can improve symptoms of suicidal thoughts and behaviors⁠[15].Atypical antipsychoticsAtypical (second generation) antipsychotics tend to have fewer side effects and tend to be more effective at decreasing impulse aggression than first generation antipsychotics. Psychotic symptoms are thought to be triggered by an overproduction of dopamine, Antipsychotics have been shown to reduce dopamine transmission, which can reduce these symptoms⁠[10].Atypical antipsychotics used to treat BPD symptoms include:Olanzapine (Zyprexa): Studies of BPD symptoms have produced limited and mixed results. These medicines are not established treatments for BPD itself; prescribing requires an individualized assessment[7].Aripiprazole (Abilify) has been shown to reduceimpulsive behavior, psychosis (loss of touch with reality), emotional instability, and interpersonal dysfunction⁠[15].Risperidone (Risperdal) has been shown to reduce experiences of psychosis and the incidence of extrapyramidal adverse effects (drug-induced movement disorder)⁠[2].Quetiapine (Seroquel): Evidence for improving BPD symptoms is limited and conflicting. These medicines are not established treatments for BPD itself; prescribing requires an individualized assessment[7].Paliperidone: A small pilot study reported symptom improvements, but this does not establish effectiveness for BPD. These medicines are not established treatments for BPD itself; prescribing requires an individualized assessment[7].Mood Stabilizers and AnticonvulsantsMood stabilizers and anticonvulsants can be used to treat BPD symptoms such as mood instability, aggression, impulsivity, and overall day to day functioning⁠[15].Mood stabilizers and anticonvulsants prescribed to treat BPD symptoms include:Carbamazepine (Tegretol): Medication is not usually the primary treatment for borderline personality disorder. If a clinician proposes a medicine alongside psychotherapy, discuss the specific symptoms or co-occurring condition being targeted, the evidence, and potential side effects⁠[15][14].Divalproex sodium (Depakote): This medication improves interpersonal sensitivity, irritability, and aggression, mainly in people with high impulsive aggression⁠[15].Lamotrigine target (Lamictal): Lamotrigine has been shown to improve anger, mood instability, and impulsivity, but there is a small risk it can cause a potentially life-threatening rash and toxicity⁠[15]. Lithium carbonate (Eskalith): This has been shown to improvemood instability and may improve overall functioning, but data is limited⁠[15]. Topiramate (Topamax): This has been shown to improve anger, anxiety, and problems maintaining relationships. Some peoplewith BPD have reported that it improves their quality of life, but it is associated with weight loss, which may be a problem for people with eating disorders⁠[15].Pregnancy-related medication risks require individual specialist review. Tell your prescriber if you are pregnant, planning pregnancy, or breastfeeding[20].AnxiolyticsAnxiolytics are medications used to treat anxiety and other mental health conditions such as panic disorders and insomnia⁠[17]. anxiolytic drugs stimulate GABA receptors, which creates calming effects⁠[1].The brain can grow accustomed to anxiety medications, which reduce their effectiveness and may require higher doses or medication changes⁠[1].Anxiety medications may be misused or abused, which can have life-threatening consequences⁠[17]. Benzodiazepines are commonly used to treat anxiety, insomnia, seizures, spastic disorders, and agitation and may be used to treat anxiety in BPD patients⁠[3]. However, the use of anxiolytics and sedatives to treat BPD should be closely monitored, since they can cause disinhibition, which can be a problem for people with BPD since they can be impulsive⁠[20]. Common benzodiazepines include: Lorazepam (Ativan): Lorazepam is a sedative that creates a calming effect. It can be helpful if used for a short time for crisis management⁠[20].Clonazepam (Klonopin): Clonazepam is used to treat panic disorder. Clonazepam may improve impulsivity and anxiety, but there is limited data available on its effectiveness⁠[8].Alprazolam (Xanax): Alprazolam is commonly used to treat anxiety and panic disorders. Alprazolam, like clonazepam, may improve impulsivity and anxiety, but there is limited data available on its effectiveness, and some data shows it might lower inhibition and control. Since BPD can cause impulsivity, this could be problematic, especially if suicidal thoughts and self-harming behaviors are present⁠[8].Diazepam (Valium): Diazepam has the same calming effect lorazepam and other benzodiazepines have. It can be helpful if used for a short period and to help manage symptoms when crisis management is necessary, such as for a short period while a patient is an inpatient⁠[20].Using benzodiazepines requires well-coordinated and planned treatment approaches, such as using time-limited prescriptions⁠[20].Common side effects of benzodiazepines include⁠[3]: HeadacheNausea or vomitingDiarrheaProblems breathing or shortness of breathRespiratory arrest (not breathing)Loss of consciousnessTremors (involuntary shaking or movements)⁠[4]Benzodiazepines can cause more severe side effects, such as angle-closure glaucoma, caused by intraocular eye pressure, which compresses the optical nerve at the back of the eye⁠[3]. Benzodiazepines should be used sparingly in pregnant and breastfeeding women, due to some potential risks to the baby⁠[3].Other medicationsChannel blockers can regulate the overactivity of the neurotransmitter glutamate⁠[3]. One study showed memantine added to another typical drug treatment improved BPD symptoms⁠[7].Opioid antagonists have been shown to reduce some self-harm behaviors⁠[7].Neuropeptides such as oxytocin, opioids, and vasopressin may help with BPD symptoms⁠[15]. The neuropeptide oxytocin has been shown to lessen threat sensitivity in patients with BPD and studies suggest that it may improve interpersonal dysfunction⁠[16].Omega-3 fatty acids have shown to improve symptoms of BPD, especially for impulsivity and mood dysregulation. Omega-3 fatty acids may be used in combination with another therapy⁠[11]. ORY-2001 (Vafidemstat) is being evaluated in clinical studies for treating central nervous system (CNS) diseases such as Alzheimer's Disease (AD) and Borderline Personality Disorder⁠[12].Preliminary studies have shown a significant reduction in neuroinflammation after six months and 12 months of treatment. ORY-2001 may reduce cognitive deterioration and normalize genes related to cognitive function, neuroplasticity, and memory⁠[12]. The first assessment on humans has proven it is safe and well tolerated⁠[12].Other BPD treatmentsSeveral types of psychotherapy have been shown as effective in the treatment and management of BPD. The most effective approaches include:Dialectical behavior therapy (DBT) DBT was developed using Cognitive behavioral therapy (CBT), for the treatment of BPD. Many therapists view DBT as the ‘gold standard’ therapeutic approach for BPD management. According to DBT, people with BPD can learn techniques that focus on interpersonal effectiveness, distress tolerance, mindfulness, and emotion regulation⁠[6].Mentalization-Based Treatment (MBT) focuses on strengthening the BPD patient’s capacity to mentally process information and understand their own and others' mental states, such as thoughts, feelings, beliefs, and behaviors, to help them make sense of them⁠[6].ReferencesAlramadhan, E., Hanna, M. S., Hanna, M. S., Goldstein, T. A., Avila, S. M., & Weeks, B. S. (2012). Dietary and botanical anxiolytics. Medical science monitor: international medical journal of experimental and clinical research, 18(4), RA40–RA48. medscimonit.com. Accessed October 10 2026.Bienefeld, D. (2021). Personality Disorders Medication. Medscape. emedicine.medscape.com.Bounds CG, Nelson VL. (2021, November 14). Benzodiazepines. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed January 12 2023.Chapman J, Jamil RT, Fleisher C. (2022, May 2). Borderline Personality Disorder. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed June 6 2023.Chu A, Wadhwa R. (2022, May 8). Selective Serotonin Reuptake Inhibitors. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed May 24 2025.Choi-Kain, L. W., Finch, E. F., Masland, S. R., Jenkins, J. A., & Unruh, B. T. (2017). What Works in the Treatment of Borderline Personality Disorder. Current behavioral neuroscience reports, 4(1), 21–30. Springer. Accessed October 10 2026.Del Casale, A., Bonanni, L., Bargagna, P., Novelli, F., Fiaschè, F., Paolini, M., Forcina, F., Anibaldi, G., Cortese, F. N., Iannuccelli, A., Adriani, B., Brugnoli, R., Girardi, P., Paris, J., & Pompili, M. (2021). Current Clinical Psychopharmacology in Borderline Personality Disorder. Current neuropharmacology, 19(10), 1760–1779. eurekaselect.com. Accessed October 10 2026.Dell'Osso, B., Albert, U., Atti, A. R., Carmassi, C., Carrà, G., Cosci, F., Del Vecchio, V., Di Nicola, M., Ferrari, S., Goracci, A., Iasevoli, F., Luciano, M., Martinotti, G., Nanni, M. G., Nivoli, A., Pinna, F., Poloni, N., Pompili, M., Sampogna, G., Tarricone, I., … Fiorillo, A. (2015). Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatric disease and treatment, 11, 1885–1909. dovepress.com.D'Souza RS, Hooten WM. (2022, August 1). Extrapyramidal Symptoms. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine.Kapur, S., Agid, O., Mizrahi, R., & Li, M. (2006). How antipsychotics work-from receptors to reality. NeuroRx: the journal of the American Society for Experimental NeuroTherapeutics, 3(1), 10–21. Springer. Accessed October 10 2026.Karaszewska, D. M., Ingenhoven, T., & Mocking, R. J. T. (2021). Marine Omega-3 Fatty Acid Supplementation for Borderline Personality Disorder: A Meta-Analysis. The Journal of clinical psychiatry, 82(3), 20r13613. psychiatrist.com. Accessed October 10 2026.Li, Y., Zhao, Y., Li, X., Zhai, L., Zheng, H., Yan, Y., Fu, Q., Ma, J., Fu, H., Zhang, Z., & Li, Z. (2022). Biological and therapeutic role of LSD1 in Alzheimer's diseases. Frontiers in pharmacology, 13, 1020556. Frontiers. Accessed October 10 2026.Olabi, B., & Hall, J. (2010). Borderline personality disorder: current drug treatments and future prospects. Therapeutic advances in chronic disease, 1(2), 59–66. SAGE Journals. Accessed October 10 2026.National Institute of Mental Health. (2025). Borderline Personality Disorder. National Institutes of Health. National Institute of Mental Health. Accessed October 10 2026.Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor & Francis.Schneider, I., Boll, S., Volman, I., Roelofs, K., Spohn, A., Herpertz, S. C., & Bertsch, K. (2020). Oxytocin Normalizes Approach-Avoidance Behavior in Women With Borderline Personality Disorder. Frontiers in psychiatry, 11, 120. Frontiers. Accessed October 10 2026.Simone CG, Bobrin BD. (2022, August 29). Anxiolytics and Sedative-Hypnotics Toxicity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine.Monoamine oxidase inhibitors (MAOIs). (n.d.). Mayo Clinic. Accessed October 10 2026.Pharmacological interventions for personality disorders. (n.d.). nice.org.uk. Accessed October 10 2026.Borderline personality disorder: management. (n.d.). pharmaceutical-journal.com. Accessed October 10 2026.Medical ContentThe Clinical Affairs Team at MentalHealth.com is a dedicated group of medical professionals with diverse and extensive clinical experience. They actively contribute to the development of content, products, and services, and meticulously review all medical material before publication to ensure accuracy and alignment with current research and conversations in mental health. For more information, please visit the Editorial Policy.About MentalHealth.comMentalHealth.com helps people understand themselves, build healthier relationships, and access the right care. We bring together mental health education, diagnostics, and care management to support well-being throughout every phase of life.AuthorJill SensenigMBAJill Sensenig is a medical writer with 16+ years experience in the healthcare industry as a writer, editor, and author.PublishedJanuary 12, 2023UpdatedAugust 27, 2025Medical ReviewerTayler HackettBSc, PGCertTalyer Hackett is a medical writer and researcher with 10+ years of experience, holding B.A. in Psychology from the University of Liverpool.ReviewedJanuary 12, 2023Related communityPersonality DisordersExplore perspectives on personality disorders, everyday experiences, and relationships.Explore communityTable of contentsChoose a sectionAntidepressantsAntipsychotics (neuroleptics)Mood Stabilizers and AnticonvulsantsAnxiolyticsOther medicationsOther BPD treatmentsView more","wordCount":2316},"schema":{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://www.mentalhealth.com/#organization","name":"MentalHealth.com","url":"https://www.mentalhealth.com/","publishingPrinciples":"https://www.mentalhealth.com/publishing/editorial-policy"},{"@type":"WebSite","@id":"https://www.mentalhealth.com/#website","url":"https://www.mentalhealth.com/","name":"MentalHealth.com","inLanguage":"en-US","publisher":{"@id":"https://www.mentalhealth.com/#organization"}},{"@type":"BreadcrumbList","@id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.mentalhealth.com/"},{"@type":"ListItem","position":2,"name":"Library","item":"https://www.mentalhealth.com/library"},{"@type":"ListItem","position":3,"name":"Personality Disorders","item":"https://www.mentalhealth.com/library/personality-disorders"},{"@type":"ListItem","position":4,"name":"Medications for Borderline Personality Disorder","item":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder"}]},{"@type":"ImageObject","@id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#primaryimage","url":"https://www.mentalhealth.com/assets/optimized/7d897f0ee39d4329bfc5ebdf.webp","contentUrl":"https://www.mentalhealth.com/assets/optimized/7d897f0ee39d4329bfc5ebdf.webp","width":1200,"height":600,"encodingFormat":"image/webp","caption":"A counselor takes notes during a conversation with an adult."},{"@type":"Person","@id":"https://www.mentalhealth.com/people/jill-sensenig#person","name":"Jill Sensenig","url":"https://www.mentalhealth.com/people/jill-sensenig","jobTitle":"MBA","image":"https://www.mentalhealth.com/assets/optimized/a31666132215697b750001da.webp","sameAs":["https://www.linkedin.com/in/jillsensenig/"],"memberOf":[{"@id":"https://www.mentalhealth.com/publishing#department"}]},{"@type":"Person","@id":"https://www.mentalhealth.com/people/tayler-hackett#person","name":"Tayler Hackett","url":"https://www.mentalhealth.com/people/tayler-hackett","jobTitle":"BSc, PGCert","image":"https://www.mentalhealth.com/assets/optimized/695fdf81224f51c976460925.webp","memberOf":[{"@id":"https://www.mentalhealth.com/clinical-affairs#department"}]},{"@type":"Article","@id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#article","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder","headline":"Medications for Borderline Personality Disorder","description":"There aren't any medications that can treat BPD, but there are drugs that can help manage symptoms of the disorder. Find out more here.","wordCount":1630,"mainEntityOfPage":{"@id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#webpage"},"publisher":{"@id":"https://www.mentalhealth.com/#organization"},"articleSection":"Personality Disorders","citation":[{"@type":"CreativeWork","name":"Alramadhan, E., Hanna, M. S., Hanna, M. S., Goldstein, T. A., Avila, S. M., & Weeks, B. S. (2012). Dietary and botanical anxiolytics. Medical science monitor: international medical journal of experimental and clinical research, 18(4), RA40–RA48. medscimonit.com. Accessed October 10 2026.","url":"https://medscimonit.com/abstract/full/idArt/882608?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Bienefeld, D. (2021). Personality Disorders Medication. Medscape. emedicine.medscape.com.","url":"https://emedicine.medscape.com/article/294307-medication?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Bounds CG, Nelson VL. (2021, November 14). Benzodiazepines. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed January 12 2023.","url":"https://www.ncbi.nlm.nih.gov/books/NBK470159/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Chapman J, Jamil RT, Fleisher C. (2022, May 2). Borderline Personality Disorder. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed June 6 2023.","url":"https://www.ncbi.nlm.nih.gov/books/NBK430883/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Chu A, Wadhwa R. (2022, May 8). Selective Serotonin Reuptake Inhibitors. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed May 24 2025.","url":"https://www.ncbi.nlm.nih.gov/books/NBK554406/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Choi-Kain, L. W., Finch, E. F., Masland, S. R., Jenkins, J. A., & Unruh, B. T. (2017). What Works in the Treatment of Borderline Personality Disorder. Current behavioral neuroscience reports, 4(1), 21–30. Springer. Accessed October 10 2026.","url":"https://link.springer.com/article/10.1007/s40473-017-0103-z?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Del Casale, A., Bonanni, L., Bargagna, P., Novelli, F., Fiaschè, F., Paolini, M., Forcina, F., Anibaldi, G., Cortese, F. N., Iannuccelli, A., Adriani, B., Brugnoli, R., Girardi, P., Paris, J., & Pompili, M. (2021). Current Clinical Psychopharmacology in Borderline Personality Disorder. Current neuropharmacology, 19(10), 1760–1779. eurekaselect.com. Accessed October 10 2026.","url":"https://www.eurekaselect.com/article/116088?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Dell'Osso, B., Albert, U., Atti, A. R., Carmassi, C., Carrà, G., Cosci, F., Del Vecchio, V., Di Nicola, M., Ferrari, S., Goracci, A., Iasevoli, F., Luciano, M., Martinotti, G., Nanni, M. G., Nivoli, A., Pinna, F., Poloni, N., Pompili, M., Sampogna, G., Tarricone, I., … Fiorillo, A. (2015). Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatric disease and treatment, 11, 1885–1909. dovepress.com.","url":"http://www.dovepress.com/bridging-the-gap-between-education-and-appropriate-use-of-benzodiazepi-peer-reviewed-article-NDT?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"D'Souza RS, Hooten WM. (2022, August 1). Extrapyramidal Symptoms. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine.","url":"https://www.ncbi.nlm.nih.gov/books/NBK534115/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Kapur, S., Agid, O., Mizrahi, R., & Li, M. (2006). How antipsychotics work-from receptors to reality. NeuroRx: the journal of the American Society for Experimental NeuroTherapeutics, 3(1), 10–21. Springer. Accessed October 10 2026.","url":"https://link.springer.com/article/10.1016/j.nurx.2005.12.003?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Karaszewska, D. M., Ingenhoven, T., & Mocking, R. J. T. (2021). Marine Omega-3 Fatty Acid Supplementation for Borderline Personality Disorder: A Meta-Analysis. The Journal of clinical psychiatry, 82(3), 20r13613. psychiatrist.com. Accessed October 10 2026.","url":"https://www.psychiatrist.com/jcp/marine-omega-3-fatty-acid-supplementation-borderline-personality-disorder-meta-analysis/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Li, Y., Zhao, Y., Li, X., Zhai, L., Zheng, H., Yan, Y., Fu, Q., Ma, J., Fu, H., Zhang, Z., & Li, Z. (2022). Biological and therapeutic role of LSD1 in Alzheimer's diseases. Frontiers in pharmacology, 13, 1020556. Frontiers. Accessed October 10 2026.","url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.1020556/full?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Olabi, B., & Hall, J. (2010). Borderline personality disorder: current drug treatments and future prospects. Therapeutic advances in chronic disease, 1(2), 59–66. SAGE Journals. Accessed October 10 2026.","url":"https://journals.sagepub.com/doi/10.1177/2040622310368455?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"National Institute of Mental Health. (2025). Borderline Personality Disorder. National Institutes of Health. National Institute of Mental Health. Accessed October 10 2026.","url":"https://www.nimh.nih.gov/health/publications/borderline-personality-disorder?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor & Francis.","url":"https://www.tandfonline.com/doi/full/10.31887/DCNS.2013.15.2/lripoll?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Schneider, I., Boll, S., Volman, I., Roelofs, K., Spohn, A., Herpertz, S. C., & Bertsch, K. (2020). Oxytocin Normalizes Approach-Avoidance Behavior in Women With Borderline Personality Disorder. Frontiers in psychiatry, 11, 120. Frontiers. Accessed October 10 2026.","url":"https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2020.00120/full?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Simone CG, Bobrin BD. (2022, August 29). Anxiolytics and Sedative-Hypnotics Toxicity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine.","url":"https://www.ncbi.nlm.nih.gov/books/NBK562309/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Monoamine oxidase inhibitors (MAOIs). (n.d.). Mayo Clinic. Accessed October 10 2026.","url":"https://www.mayoclinic.org/diseases-conditions/depression/in-depth/maois/art-20043992?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Pharmacological interventions for personality disorders. (n.d.). nice.org.uk. Accessed October 10 2026.","url":"https://www.nice.org.uk/guidance/qs88/chapter/Quality-statement-4-Pharmacological-interventions?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Borderline personality disorder: management. (n.d.). pharmaceutical-journal.com. Accessed October 10 2026.","url":"https://pharmaceutical-journal.com/article/ld/borderline-personality-disorder-management?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"}],"inLanguage":"en-US","author":[{"@id":"https://www.mentalhealth.com/people/jill-sensenig#person"}],"image":{"@id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#primaryimage"},"about":{"@type":"Thing","@id":"https://www.mentalhealth.com/library/personality-disorders#topic","name":"Personality Disorders"},"datePublished":"2023-01-12T11:53:33Z","dateModified":"2025-08-27T10:56:54Z"},{"@type":"MedicalWebPage","@id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#webpage","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder","name":"Medications for Borderline Personality Disorder","description":"There aren't any medications that can treat BPD, but there are drugs that can help manage symptoms of the disorder. Find out more here.","inLanguage":"en-US","isPartOf":{"@id":"https://www.mentalhealth.com/library/personality-disorders#webpage"},"breadcrumb":{"@id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#breadcrumb"},"mainEntity":{"@id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#article"},"relatedLink":["https://www.mentalhealth.com/library/why-is-it-called-borderline-personality-disorder","https://www.mentalhealth.com/library/nine-symptoms-of-borderline-personality-disorder","https://www.mentalhealth.com/library/is-borderline-personality-disorder-genetic","https://www.mentalhealth.com/library/is-there-a-cure-for-borderline-personality-disorder","https://www.mentalhealth.com/library/borderline-personality-disorder-therapies","https://www.mentalhealth.com/people/simone-hoermann"],"publisher":{"@id":"https://www.mentalhealth.com/#organization"},"medicalAudience":{"@type":"MedicalAudience","audienceType":"General public"},"primaryImageOfPage":{"@id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#primaryimage"},"image":{"@id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#primaryimage"},"reviewedBy":{"@id":"https://www.mentalhealth.com/people/tayler-hackett#person"},"about":{"@type":"Thing","@id":"https://www.mentalhealth.com/library/personality-disorders#topic","name":"Personality Disorders"},"citation":[{"@type":"CreativeWork","name":"Alramadhan, E., Hanna, M. S., Hanna, M. S., Goldstein, T. A., Avila, S. M., & Weeks, B. S. (2012). Dietary and botanical anxiolytics. Medical science monitor: international medical journal of experimental and clinical research, 18(4), RA40–RA48. medscimonit.com. Accessed October 10 2026.","url":"https://medscimonit.com/abstract/full/idArt/882608?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Bienefeld, D. (2021). Personality Disorders Medication. Medscape. emedicine.medscape.com.","url":"https://emedicine.medscape.com/article/294307-medication?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Bounds CG, Nelson VL. (2021, November 14). Benzodiazepines. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed January 12 2023.","url":"https://www.ncbi.nlm.nih.gov/books/NBK470159/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Chapman J, Jamil RT, Fleisher C. (2022, May 2). Borderline Personality Disorder. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed June 6 2023.","url":"https://www.ncbi.nlm.nih.gov/books/NBK430883/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Chu A, Wadhwa R. (2022, May 8). Selective Serotonin Reuptake Inhibitors. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed May 24 2025.","url":"https://www.ncbi.nlm.nih.gov/books/NBK554406/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Choi-Kain, L. W., Finch, E. F., Masland, S. R., Jenkins, J. A., & Unruh, B. T. (2017). What Works in the Treatment of Borderline Personality Disorder. Current behavioral neuroscience reports, 4(1), 21–30. Springer. Accessed October 10 2026.","url":"https://link.springer.com/article/10.1007/s40473-017-0103-z?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Del Casale, A., Bonanni, L., Bargagna, P., Novelli, F., Fiaschè, F., Paolini, M., Forcina, F., Anibaldi, G., Cortese, F. N., Iannuccelli, A., Adriani, B., Brugnoli, R., Girardi, P., Paris, J., & Pompili, M. (2021). Current Clinical Psychopharmacology in Borderline Personality Disorder. Current neuropharmacology, 19(10), 1760–1779. eurekaselect.com. Accessed October 10 2026.","url":"https://www.eurekaselect.com/article/116088?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Dell'Osso, B., Albert, U., Atti, A. R., Carmassi, C., Carrà, G., Cosci, F., Del Vecchio, V., Di Nicola, M., Ferrari, S., Goracci, A., Iasevoli, F., Luciano, M., Martinotti, G., Nanni, M. G., Nivoli, A., Pinna, F., Poloni, N., Pompili, M., Sampogna, G., Tarricone, I., … Fiorillo, A. (2015). Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatric disease and treatment, 11, 1885–1909. dovepress.com.","url":"http://www.dovepress.com/bridging-the-gap-between-education-and-appropriate-use-of-benzodiazepi-peer-reviewed-article-NDT?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"D'Souza RS, Hooten WM. (2022, August 1). Extrapyramidal Symptoms. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine.","url":"https://www.ncbi.nlm.nih.gov/books/NBK534115/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Kapur, S., Agid, O., Mizrahi, R., & Li, M. (2006). How antipsychotics work-from receptors to reality. NeuroRx: the journal of the American Society for Experimental NeuroTherapeutics, 3(1), 10–21. Springer. Accessed October 10 2026.","url":"https://link.springer.com/article/10.1016/j.nurx.2005.12.003?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Karaszewska, D. M., Ingenhoven, T., & Mocking, R. J. T. (2021). Marine Omega-3 Fatty Acid Supplementation for Borderline Personality Disorder: A Meta-Analysis. The Journal of clinical psychiatry, 82(3), 20r13613. psychiatrist.com. Accessed October 10 2026.","url":"https://www.psychiatrist.com/jcp/marine-omega-3-fatty-acid-supplementation-borderline-personality-disorder-meta-analysis/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Li, Y., Zhao, Y., Li, X., Zhai, L., Zheng, H., Yan, Y., Fu, Q., Ma, J., Fu, H., Zhang, Z., & Li, Z. (2022). Biological and therapeutic role of LSD1 in Alzheimer's diseases. Frontiers in pharmacology, 13, 1020556. Frontiers. Accessed October 10 2026.","url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.1020556/full?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Olabi, B., & Hall, J. (2010). Borderline personality disorder: current drug treatments and future prospects. Therapeutic advances in chronic disease, 1(2), 59–66. SAGE Journals. Accessed October 10 2026.","url":"https://journals.sagepub.com/doi/10.1177/2040622310368455?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"National Institute of Mental Health. (2025). Borderline Personality Disorder. National Institutes of Health. National Institute of Mental Health. Accessed October 10 2026.","url":"https://www.nimh.nih.gov/health/publications/borderline-personality-disorder?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor & Francis.","url":"https://www.tandfonline.com/doi/full/10.31887/DCNS.2013.15.2/lripoll?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Schneider, I., Boll, S., Volman, I., Roelofs, K., Spohn, A., Herpertz, S. C., & Bertsch, K. (2020). Oxytocin Normalizes Approach-Avoidance Behavior in Women With Borderline Personality Disorder. Frontiers in psychiatry, 11, 120. Frontiers. Accessed October 10 2026.","url":"https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2020.00120/full?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Simone CG, Bobrin BD. (2022, August 29). Anxiolytics and Sedative-Hypnotics Toxicity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine.","url":"https://www.ncbi.nlm.nih.gov/books/NBK562309/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Monoamine oxidase inhibitors (MAOIs). (n.d.). Mayo Clinic. Accessed October 10 2026.","url":"https://www.mayoclinic.org/diseases-conditions/depression/in-depth/maois/art-20043992?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Pharmacological interventions for personality disorders. (n.d.). nice.org.uk. Accessed October 10 2026.","url":"https://www.nice.org.uk/guidance/qs88/chapter/Quality-statement-4-Pharmacological-interventions?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"@type":"CreativeWork","name":"Borderline personality disorder: management. (n.d.). pharmaceutical-journal.com. Accessed October 10 2026.","url":"https://pharmaceutical-journal.com/article/ld/borderline-personality-disorder-management?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"}],"datePublished":"2023-01-12T11:53:33Z","dateModified":"2025-08-27T10:56:54Z","lastReviewed":"2023-01-12"}]},"representations":{"html":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder","json":"https://www.mentalhealth.com/data/library/medication-for-borderline-personality-disorder.json","jsonLd":"https://www.mentalhealth.com/data/library/medication-for-borderline-personality-disorder.ld.json"},"$schema":"https://www.mentalhealth.com/data/page.schema.json","images":[{"url":"https://www.mentalhealth.com/assets/optimized/a31666132215697b750001da.webp","alt":"","width":22,"height":22},{"url":"https://www.mentalhealth.com/assets/optimized/695fdf81224f51c976460925.webp","alt":"","width":22,"height":22},{"url":"https://www.mentalhealth.com/assets/optimized/7d897f0ee39d4329bfc5ebdf.webp","alt":"A counselor takes notes during a conversation with an adult.","width":1200,"height":600},{"url":"https://www.mentalhealth.com/assets/optimized/5ffe249a46895c9a14f6074b.jpg","alt":"","width":64,"height":64},{"url":"https://www.mentalhealth.com/assets/optimized/fa1c8ddf348e3d714ce03a89.webp","alt":"","width":48,"height":48}],"sections":[{"title":"Key takeaways","id":"key-takeaways","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#key-takeaways","level":2},{"title":"Antidepressants","id":"antidepressants","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#antidepressants","level":2},{"title":"Serotonin reuptake inhibitors (SSRIs)","id":"serotonin-reuptake-inhibitors-ssris","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#serotonin-reuptake-inhibitors-ssris","level":3},{"title":"Monoamine oxidase inhibitors (MAOIs)","id":"monoamine-oxidase-inhibitors-maois","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#monoamine-oxidase-inhibitors-maois","level":3},{"title":"Antipsychotics (neuroleptics)","id":"antipsychotics-neuroleptics","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#antipsychotics-neuroleptics","level":2},{"title":"First generation antipsychotics","id":"first-generation-antipsychotics","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#first-generation-antipsychotics","level":3},{"title":"Atypical antipsychotics","id":"atypical-antipsychotics","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#atypical-antipsychotics","level":3},{"title":"Mood Stabilizers and Anticonvulsants","id":"mood-stabilizers-and-anticonvulsants","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#mood-stabilizers-and-anticonvulsants","level":2},{"title":"Anxiolytics","id":"anxiolytics","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#anxiolytics","level":2},{"title":"Other medications","id":"other-medications","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#other-medications","level":2},{"title":"Other BPD treatments","id":"other-bpd-treatments","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#other-bpd-treatments","level":2},{"title":"References","id":"references-2","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#references-2","level":2},{"title":"Medical Content","id":"medical-content","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#medical-content","level":2},{"title":"About MentalHealth.com","id":"about-mentalhealth-com","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#about-mentalhealth-com","level":2},{"title":"Jill Sensenig","id":"jill-sensenig","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#jill-sensenig","level":3},{"title":"Tayler Hackett","id":"tayler-hackett","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#tayler-hackett","level":3}],"references":[{"number":1,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#dietary-botanical-anxiolytics","text":"Alramadhan, E., Hanna, M. S., Hanna, M. S., Goldstein, T. A., Avila, S. M., & Weeks, B. S. (2012). Dietary and botanical anxiolytics. Medical science monitor: international medical journal of experimental and clinical research, 18(4), RA40–RA48. medscimonit.com. Accessed October 10 2026.","links":[{"url":"https://medscimonit.com/abstract/full/idArt/882608?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"medscimonit.com"}],"url":"https://medscimonit.com/abstract/full/idArt/882608?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":2,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#personality-disorders-medication","text":"Bienefeld, D. (2021). Personality Disorders Medication. Medscape. emedicine.medscape.com.","links":[{"url":"https://emedicine.medscape.com/article/294307-medication?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"emedicine.medscape.com"}],"url":"https://emedicine.medscape.com/article/294307-medication?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":3,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan","text":"Bounds CG, Nelson VL. (2021, November 14). Benzodiazepines. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed January 12 2023.","links":[{"url":"https://www.ncbi.nlm.nih.gov/books/NBK470159/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"National Library of Medicine"}],"url":"https://www.ncbi.nlm.nih.gov/books/NBK470159/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":4,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan-source","text":"Chapman J, Jamil RT, Fleisher C. (2022, May 2). Borderline Personality Disorder. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed June 6 2023.","links":[{"url":"https://www.ncbi.nlm.nih.gov/books/NBK430883/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"National Library of Medicine"}],"url":"https://www.ncbi.nlm.nih.gov/books/NBK430883/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":5,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#selective-serotonin-reuptake-inhibitors","text":"Chu A, Wadhwa R. (2022, May 8). Selective Serotonin Reuptake Inhibitors. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine. Accessed May 24 2025.","links":[{"url":"https://www.ncbi.nlm.nih.gov/books/NBK554406/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"National Library of Medicine"}],"url":"https://www.ncbi.nlm.nih.gov/books/NBK554406/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":6,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#works-treatment-borderline-personality-disorder","text":"Choi-Kain, L. W., Finch, E. F., Masland, S. R., Jenkins, J. A., & Unruh, B. T. (2017). What Works in the Treatment of Borderline Personality Disorder. Current behavioral neuroscience reports, 4(1), 21–30. Springer. Accessed October 10 2026.","links":[{"url":"https://link.springer.com/article/10.1007/s40473-017-0103-z?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"Springer"}],"url":"https://link.springer.com/article/10.1007/s40473-017-0103-z?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":7,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#current-clinical-psychopharmacology-borderline-personality-disorder","text":"Del Casale, A., Bonanni, L., Bargagna, P., Novelli, F., Fiaschè, F., Paolini, M., Forcina, F., Anibaldi, G., Cortese, F. N., Iannuccelli, A., Adriani, B., Brugnoli, R., Girardi, P., Paris, J., & Pompili, M. (2021). Current Clinical Psychopharmacology in Borderline Personality Disorder. Current neuropharmacology, 19(10), 1760–1779. eurekaselect.com. Accessed October 10 2026.","links":[{"url":"https://www.eurekaselect.com/article/116088?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"eurekaselect.com"}],"url":"https://www.eurekaselect.com/article/116088?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":8,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#bridging-gap-between-education-appropriate-use-benzodiazepines-psychiatric-clinical","text":"Dell'Osso, B., Albert, U., Atti, A. R., Carmassi, C., Carrà, G., Cosci, F., Del Vecchio, V., Di Nicola, M., Ferrari, S., Goracci, A., Iasevoli, F., Luciano, M., Martinotti, G., Nanni, M. G., Nivoli, A., Pinna, F., Poloni, N., Pompili, M., Sampogna, G., Tarricone, I., … Fiorillo, A. (2015). Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatric disease and treatment, 11, 1885–1909. dovepress.com.","links":[{"url":"http://www.dovepress.com/bridging-the-gap-between-education-and-appropriate-use-of-benzodiazepi-peer-reviewed-article-NDT?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"dovepress.com"}],"url":"http://www.dovepress.com/bridging-the-gap-between-education-and-appropriate-use-of-benzodiazepi-peer-reviewed-article-NDT?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":9,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan-2","text":"D'Souza RS, Hooten WM. (2022, August 1). Extrapyramidal Symptoms. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine.","links":[{"url":"https://www.ncbi.nlm.nih.gov/books/NBK534115/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"National Library of Medicine"}],"url":"https://www.ncbi.nlm.nih.gov/books/NBK534115/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":10,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#antipsychotics-work-receptors-reality","text":"Kapur, S., Agid, O., Mizrahi, R., & Li, M. (2006). How antipsychotics work-from receptors to reality. NeuroRx: the journal of the American Society for Experimental NeuroTherapeutics, 3(1), 10–21. Springer. Accessed October 10 2026.","links":[{"url":"https://link.springer.com/article/10.1016/j.nurx.2005.12.003?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"Springer"}],"url":"https://link.springer.com/article/10.1016/j.nurx.2005.12.003?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":11,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#marine-omega-3-fatty-acid-supplementation-borderline-personality-disorder","text":"Karaszewska, D. M., Ingenhoven, T., & Mocking, R. J. T. (2021). Marine Omega-3 Fatty Acid Supplementation for Borderline Personality Disorder: A Meta-Analysis. The Journal of clinical psychiatry, 82(3), 20r13613. psychiatrist.com. Accessed October 10 2026.","links":[{"url":"https://www.psychiatrist.com/jcp/marine-omega-3-fatty-acid-supplementation-borderline-personality-disorder-meta-analysis/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"psychiatrist.com"}],"url":"https://www.psychiatrist.com/jcp/marine-omega-3-fatty-acid-supplementation-borderline-personality-disorder-meta-analysis/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":12,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#biological-therapeutic-role-lsd1-alzheimer-s-diseases","text":"Li, Y., Zhao, Y., Li, X., Zhai, L., Zheng, H., Yan, Y., Fu, Q., Ma, J., Fu, H., Zhang, Z., & Li, Z. (2022). Biological and therapeutic role of LSD1 in Alzheimer's diseases. Frontiers in pharmacology, 13, 1020556. Frontiers. Accessed October 10 2026.","links":[{"url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.1020556/full?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"Frontiers"}],"url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.1020556/full?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":13,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#borderline-personality-disorder-current-drug-treatments-future-prospects","text":"Olabi, B., & Hall, J. (2010). Borderline personality disorder: current drug treatments and future prospects. Therapeutic advances in chronic disease, 1(2), 59–66. SAGE Journals. Accessed October 10 2026.","links":[{"url":"https://journals.sagepub.com/doi/10.1177/2040622310368455?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"SAGE Journals"}],"url":"https://journals.sagepub.com/doi/10.1177/2040622310368455?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":14,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#www-sciencedirect-com","text":"National Institute of Mental Health. (2025). Borderline Personality Disorder. National Institutes of Health. National Institute of Mental Health. Accessed October 10 2026.","links":[{"url":"https://www.nimh.nih.gov/health/publications/borderline-personality-disorder?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"National Institute of Mental Health"}],"url":"https://www.nimh.nih.gov/health/publications/borderline-personality-disorder?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":15,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder","text":"Ripoll L. H. (2013). Psychopharmacologic treatment of borderline personality disorder. Dialogues in clinical neuroscience, 15(2), 213–224. Taylor & Francis.","links":[{"url":"https://www.tandfonline.com/doi/full/10.31887/DCNS.2013.15.2/lripoll?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"Taylor & Francis"}],"url":"https://www.tandfonline.com/doi/full/10.31887/DCNS.2013.15.2/lripoll?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":16,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#oxytocin-normalizes-approach-avoidance-behavior-women-borderline-personality-disorder","text":"Schneider, I., Boll, S., Volman, I., Roelofs, K., Spohn, A., Herpertz, S. C., & Bertsch, K. (2020). Oxytocin Normalizes Approach-Avoidance Behavior in Women With Borderline Personality Disorder. Frontiers in psychiatry, 11, 120. Frontiers. Accessed October 10 2026.","links":[{"url":"https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2020.00120/full?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"Frontiers"}],"url":"https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2020.00120/full?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":17,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#anxiolytics-sedative-hypnotics-toxicity","text":"Simone CG, Bobrin BD. (2022, August 29). Anxiolytics and Sedative-Hypnotics Toxicity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. National Library of Medicine.","links":[{"url":"https://www.ncbi.nlm.nih.gov/books/NBK562309/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"National Library of Medicine"}],"url":"https://www.ncbi.nlm.nih.gov/books/NBK562309/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":18,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-18","text":"Monoamine oxidase inhibitors (MAOIs). (n.d.). Mayo Clinic. Accessed October 10 2026.","links":[{"url":"https://www.mayoclinic.org/diseases-conditions/depression/in-depth/maois/art-20043992?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"Mayo Clinic"}],"url":"https://www.mayoclinic.org/diseases-conditions/depression/in-depth/maois/art-20043992?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":19,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-19","text":"Pharmacological interventions for personality disorders. (n.d.). nice.org.uk. Accessed October 10 2026.","links":[{"url":"https://www.nice.org.uk/guidance/qs88/chapter/Quality-statement-4-Pharmacological-interventions?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"nice.org.uk"}],"url":"https://www.nice.org.uk/guidance/qs88/chapter/Quality-statement-4-Pharmacological-interventions?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"},{"number":20,"id":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-20","text":"Borderline personality disorder: management. (n.d.). pharmaceutical-journal.com. Accessed October 10 2026.","links":[{"url":"https://pharmaceutical-journal.com/article/ld/borderline-personality-disorder-management?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"pharmaceutical-journal.com"}],"url":"https://pharmaceutical-journal.com/article/ld/borderline-personality-disorder-management?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com"}],"relatedReading":[],"links":[{"url":"https://www.mentalhealth.com/","label":"Home"},{"url":"https://www.mentalhealth.com/library","label":"Library"},{"url":"https://www.mentalhealth.com/library/personality-disorders","label":"Personality Disorders"},{"url":"https://www.mentalhealth.com/people/jill-sensenig","label":"Jill Sensenig"},{"url":"https://www.mentalhealth.com/people/tayler-hackett","label":"Tayler Hackett"},{"url":"https://www.mentalhealth.com/library/borderline-personality-disorder","label":"borderline personality disorder (BPD)"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan-source","label":"[4]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan-source","label":"[4]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-19","label":"[19]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#selective-serotonin-reuptake-inhibitors","label":"[5]"},{"url":"https://www.mentalhealth.com/library/how-to-handle-bpd-rage","label":"inappropriate and excessive anger or rage"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#selective-serotonin-reuptake-inhibitors","label":"[5]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#selective-serotonin-reuptake-inhibitors","label":"[5]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#selective-serotonin-reuptake-inhibitors","label":"[5]"},{"url":"https://www.mentalhealth.com/library/fluoxetine-uses-dosage-side-effects","label":"Fluoxetine (Prozac)"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#bridging-gap-between-education-appropriate-use-benzodiazepines-psychiatric-clinical","label":"[8]"},{"url":"https://www.mentalhealth.com/library/fluvoxamine-uses-dosage-side-effects","label":"Fluvoxamine (Luvox)"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder","label":"[15]"},{"url":"https://www.mentalhealth.com/library/paroxetine-uses-dosage-side-effects","label":"Paroxetine (Paxil)"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder","label":"[15]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-18","label":"[18]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-18","label":"[18]"},{"url":"https://www.mentalhealth.com/library/phenelzine-uses-dosage-side-effects","label":"phenelzine (Nardil)"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder","label":"[15]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder","label":"[15]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#borderline-personality-disorder-current-drug-treatments-future-prospects","label":"[13]"},{"url":"https://www.mentalhealth.com/people/simone-hoermann","label":"Simone Hoermann Ph.D."},{"url":"https://www.mentalhealth.com/people/simone-hoermann","label":"View experience"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan-2","label":"[9]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder","label":"[15]"},{"url":"https://www.mentalhealth.com/library/haloperidol-uses-dosage-side-effects","label":"Haloperidol (Haldol)"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder","label":"[15]"},{"url":"https://www.mentalhealth.com/library/loxapine-uses-dosage-side-effects","label":"Loxapine (Loxitane)"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder","label":"[15]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder","label":"[15]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#antipsychotics-work-receptors-reality","label":"[10]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#current-clinical-psychopharmacology-borderline-personality-disorder","label":"[7]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder","label":"[15]"},{"url":"https://www.mentalhealth.com/library/risperidone-use-doses-side-effects","label":"Risperidone (Risperdal)"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#personality-disorders-medication","label":"[2]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#current-clinical-psychopharmacology-borderline-personality-disorder","label":"[7]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#current-clinical-psychopharmacology-borderline-personality-disorder","label":"[7]"},{"url":"https://www.mentalhealth.com/library/mood-stabilizers","label":"Mood stabilizers"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder","label":"[15]"},{"url":"https://www.mentalhealth.com/library/carbamazepine-uses-dosage-effects","label":"Carbamazepine (Tegretol)"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder","label":"[15]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#www-sciencedirect-com","label":"[14]"},{"url":"https://www.mentalhealth.com/library/divalproex-sodium-uses-dosage-side-effects","label":"Divalproex sodium (Depakote)"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder","label":"[15]"},{"url":"https://www.mentalhealth.com/library/lamotrigine-uses-dosage-side-effects","label":"Lamotrigine target (Lamictal)"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder","label":"[15]"},{"url":"https://www.mentalhealth.com/library/lithium-carbonate-uses-dosage-side-effects","label":"Lithium carbonate (Eskalith)"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder","label":"[15]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder","label":"[15]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-20","label":"[20]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#anxiolytics-sedative-hypnotics-toxicity","label":"[17]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#dietary-botanical-anxiolytics","label":"[1]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#dietary-botanical-anxiolytics","label":"[1]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#anxiolytics-sedative-hypnotics-toxicity","label":"[17]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan","label":"[3]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-20","label":"[20]"},{"url":"https://www.mentalhealth.com/library/lorazepam-uses-dosage-side-effects","label":"Lorazepam (Ativan)"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-20","label":"[20]"},{"url":"https://www.mentalhealth.com/library/clonazepam-uses-dosage-side-effects","label":"Clonazepam (Klonopin)"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#bridging-gap-between-education-appropriate-use-benzodiazepines-psychiatric-clinical","label":"[8]"},{"url":"https://www.mentalhealth.com/library/alprazolam-xanax-uses-dosage-side-effects","label":"Alprazolam (Xanax)"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#bridging-gap-between-education-appropriate-use-benzodiazepines-psychiatric-clinical","label":"[8]"},{"url":"https://www.mentalhealth.com/library/diazepam-uses-dosage-side-effects","label":"Diazepam (Valium)"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-20","label":"[20]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#verified-source-370-20","label":"[20]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan","label":"[3]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan-source","label":"[4]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan","label":"[3]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan","label":"[3]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#treasure-island-fl-statpearls-publishing-2022-jan","label":"[3]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#current-clinical-psychopharmacology-borderline-personality-disorder","label":"[7]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#current-clinical-psychopharmacology-borderline-personality-disorder","label":"[7]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#psychopharmacologic-treatment-borderline-personality-disorder","label":"[15]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#oxytocin-normalizes-approach-avoidance-behavior-women-borderline-personality-disorder","label":"[16]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#marine-omega-3-fatty-acid-supplementation-borderline-personality-disorder","label":"[11]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#biological-therapeutic-role-lsd1-alzheimer-s-diseases","label":"[12]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#biological-therapeutic-role-lsd1-alzheimer-s-diseases","label":"[12]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#biological-therapeutic-role-lsd1-alzheimer-s-diseases","label":"[12]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#works-treatment-borderline-personality-disorder","label":"[6]"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#works-treatment-borderline-personality-disorder","label":"[6]"},{"url":"https://medscimonit.com/abstract/full/idArt/882608?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"medscimonit.com"},{"url":"https://emedicine.medscape.com/article/294307-medication?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"emedicine.medscape.com"},{"url":"https://www.ncbi.nlm.nih.gov/books/NBK470159/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"National Library of Medicine"},{"url":"https://www.ncbi.nlm.nih.gov/books/NBK430883/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"National Library of Medicine"},{"url":"https://www.ncbi.nlm.nih.gov/books/NBK554406/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"National Library of Medicine"},{"url":"https://link.springer.com/article/10.1007/s40473-017-0103-z?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"Springer"},{"url":"https://www.eurekaselect.com/article/116088?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"eurekaselect.com"},{"url":"http://www.dovepress.com/bridging-the-gap-between-education-and-appropriate-use-of-benzodiazepi-peer-reviewed-article-NDT?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"dovepress.com"},{"url":"https://www.ncbi.nlm.nih.gov/books/NBK534115/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"National Library of Medicine"},{"url":"https://link.springer.com/article/10.1016/j.nurx.2005.12.003?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"Springer"},{"url":"https://www.psychiatrist.com/jcp/marine-omega-3-fatty-acid-supplementation-borderline-personality-disorder-meta-analysis/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"psychiatrist.com"},{"url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.1020556/full?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"Frontiers"},{"url":"https://journals.sagepub.com/doi/10.1177/2040622310368455?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"SAGE Journals"},{"url":"https://www.nimh.nih.gov/health/publications/borderline-personality-disorder?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"National Institute of Mental Health"},{"url":"https://www.tandfonline.com/doi/full/10.31887/DCNS.2013.15.2/lripoll?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"Taylor & Francis"},{"url":"https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2020.00120/full?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"Frontiers"},{"url":"https://www.ncbi.nlm.nih.gov/books/NBK562309/?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"National Library of Medicine"},{"url":"https://www.mayoclinic.org/diseases-conditions/depression/in-depth/maois/art-20043992?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"Mayo Clinic"},{"url":"https://www.nice.org.uk/guidance/qs88/chapter/Quality-statement-4-Pharmacological-interventions?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"nice.org.uk"},{"url":"https://pharmaceutical-journal.com/article/ld/borderline-personality-disorder-management?utm_medium=referral&utm_campaign=libra&utm_content=external_resource&utm_id=site-library-medication-for-borderline-personality-disorder&utm_source=mentalhealth.com","label":"pharmaceutical-journal.com"},{"url":"https://www.mentalhealth.com/clinical-affairs","label":"The Clinical Affairs Team"},{"url":"https://www.mentalhealth.com/publishing/editorial-policy","label":"Editorial Policy"},{"url":"https://www.mentalhealth.com/people/jill-sensenig","label":"Jill Sensenig"},{"url":"https://www.mentalhealth.com/people/tayler-hackett","label":"Tayler Hackett"},{"url":"https://www.mentalhealth.com/community/personality-disorders","label":"Explore community"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#antidepressants","label":"Antidepressants"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#antipsychotics-neuroleptics","label":"Antipsychotics (neuroleptics)"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#mood-stabilizers-and-anticonvulsants","label":"Mood Stabilizers and Anticonvulsants"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#anxiolytics","label":"Anxiolytics"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#other-medications","label":"Other medications"},{"url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#other-bpd-treatments","label":"Other BPD treatments"}],"seo":{"title":"Medications for Borderline Personality Disorder | MentalHealth.com","description":"There aren't any medications that can treat BPD, but there are drugs that can help manage symptoms of the disorder. Find out more here.","canonical":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder","robots":"index,follow","socialImage":{"url":"https://www.mentalhealth.com/assets/optimized/ec9b0cb47c0207d45e88634d.png","width":1200,"height":630,"alt":"MentalHealth.com — Library","type":"image/png","sitemapGroup":"library"}},"breadcrumbs":[{"name":"Home","url":"https://www.mentalhealth.com/"},{"name":"Library","url":"https://www.mentalhealth.com/library"},{"name":"Personality Disorders","url":"https://www.mentalhealth.com/library/personality-disorders"},{"name":"Medications for Borderline Personality Disorder","url":"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder"}],"subjectMatterExpert":{"name":"Simone Hoermann, Ph.D.","url":"/people/simone-hoermann","profileId":"6419","topic":"mood","focus":"Personality disorders, anxiety, and depression","selectionBasis":"Documented expertise in the existing published profile","reviewAttribution":false},"keyTakeaways":["Medication is sometimes used to target particular symptoms or coexisting conditions in borderline personality disorder.","Potential benefits need to be weighed against adverse effects, limited evidence, and risks such as disinhibition with some sedatives.","Structured psychotherapy remains central, with approaches such as DBT and mentalization-based treatment developing coping and relationship skills."],"introduction":{"html":"There are no medications specifically approved by the U.S. Food and Drug Administration (FDA) to treat <a href=\"https://www.mentalhealth.com/library/borderline-personality-disorder\">borderline personality disorder (BPD)</a>. <sup><a href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#resource-4\">[4]</a></sup> However, prescription medications are often used to manage the symptoms that occur with BPD, such as anxiety, sleep problems, depression, aggression, mood swings, impulsivity, or psychotic symptoms. <sup><a href=\"https://www.mentalhealth.com/library/medication-for-borderline-personality-disorder#resource-4\">[4]</a></sup> This includes medications such as antidepressants, antipsychotics, mood stabilizers, and anxiolytics (anxiety medications).","text":"There are no medications specifically approved by the U.S. Food and Drug Administration (FDA) to treat borderline personality disorder (BPD). [4] However, prescription medications are often used to manage the symptoms that occur with BPD, such as anxiety, sleep problems, depression, aggression, mood swings, impulsivity, or psychotic symptoms. [4] This includes medications such as antidepressants, antipsychotics, mood stabilizers, and anxiolytics (anxiety medications).","sourceField":"hero"},"navigation":[{"label":"Antidepressants","href":"#antidepressants","heading":"Antidepressants"},{"label":"Antipsychotics (neuroleptics)","href":"#antipsychotics-neuroleptics","heading":"Antipsychotics (neuroleptics)"},{"label":"Mood Stabilizers and Anticonvulsants","href":"#mood-stabilizers-and-anticonvulsants","heading":"Mood Stabilizers and Anticonvulsants"},{"label":"Anxiolytics","href":"#anxiolytics","heading":"Anxiolytics"},{"label":"Other medications","href":"#other-medications","heading":"Other medications"},{"label":"Other BPD treatments","href":"#other-bpd-treatments","heading":"Other BPD treatments"}],"relatedCommunity":{"community":"/community/personality-disorders","basis":"topic match"},"referencePresentation":"Numbered author–date references with italic work titles, publication details, linked source names, and documented access dates. Missing publication dates use n.d.","collections":[]}
